Energy Conservation via Thioesters in a Non-Enzymatic ...
Transcript of Energy Conservation via Thioesters in a Non-Enzymatic ...
doi.org/10.26434/chemrxiv.8832425.v1
Energy Conservation via Thioesters in a Non-Enzymatic Metabolism-likeReaction NetworkElodie Chevallot-Beroux, Jan Gorges, Joseph Moran
Submitted date: 09/07/2019 • Posted date: 09/07/2019Licence: CC BY-NC-ND 4.0Citation information: Chevallot-Beroux, Elodie; Gorges, Jan; Moran, Joseph (2019): Energy Conservation viaThioesters in a Non-Enzymatic Metabolism-like Reaction Network. ChemRxiv. Preprint.
Life’s catabolic processes capture chemical energy from the oxidative breakdown of metabolites. In thecatabolic pathways at the core of biochemistry, the oxidation of α-ketoacids or aldehydes is coupled to thesynthesis of thioesters, whose energy-releasing hydrolysis is in turn coupled to the production of adenosine5’-triphosphate (ATP). How these processes became linked before life emerged, and thus how the frameworkfor modern bioenergetics was established, is a major problem for understanding the origins of biochemistry.The structure of biochemical networks suggests that the intermediary role of thioesters in biological energyflows, and their central role in biosynthesis, is a consequence of their entry into metabolism at the earlieststage of biochemical evolution. However, how thioesters could have become embedded within a metabolicnetwork before the advent of enzymes remains unclear. Here we demonstrate non-enzymatic oxidant- orlight-driven thioester synthesis from biological α-ketoacids and show it can be integrated within aniron-promoted metabolism-like reaction network. The thioesters obtained are those predicted to be pivotal incomputational reconstructions of primitive biochemical networks (acetyl, malonyl, malyl and succinylthioesters), demonstrating a rare convergence between top-down and bottom-up approaches to the origins ofmetabolism. The diversity and simplicity of conditions that form thioesters from core metabolites suggests theenergetic link between thioester synthesis and catabolism was in place at the earliest stage of prebioticchemistry, constraining the path for the later evolution of life’s phosphorus-based energy currencies.
File list (2)
download fileview on ChemRxivthioesters v14.pdf (220.89 KiB)
download fileview on ChemRxivSupporting Information V-14.pdf (6.31 MiB)
Energy conservation via thioesters in a non-enzymatic 1 metabolism-like reaction network 2 3 Elodie Chevallot-Beroux,‡ Jan Gorges,‡ Joseph Moran* 4 5 Université de Strasbourg, CNRS, ISIS, 8 allée Gaspard Monge, 67000 Strasbourg, France 6 *[email protected], ‡these authors contributed equally to this work 7
Life’s catabolic processes capture chemical energy from the oxidative breakdown of 8
metabolites. In the catabolic pathways at the core of biochemistry, the oxidation of α-9
ketoacids or aldehydes is coupled to the synthesis of thioesters, whose energy-releasing 10
hydrolysis is in turn coupled to the production of adenosine 5’-triphosphate (ATP). How these 11
processes became linked before life emerged, and thus how the framework for modern 12
bioenergetics was established, is a major problem for understanding the origins of 13
biochemistry. The structure of biochemical networks suggests that the intermediary role of 14
thioesters in biological energy flows, and their central role in biosynthesis, is a consequence 15
of their entry into metabolism at the earliest stage of biochemical evolution. However, how 16
thioesters could have become embedded within a metabolic network before the advent of 17
enzymes remains unclear. Here we demonstrate non-enzymatic oxidant- or light-driven 18
thioester synthesis from biological α-ketoacids and show it can be integrated within an iron-19
promoted metabolism-like reaction network. The thioesters obtained are those predicted to be 20
pivotal in computational reconstructions of primitive biochemical networks (acetyl, malonyl, 21
malyl and succinyl thioesters), demonstrating a rare convergence between top-down and 22
bottom-up approaches to the origins of metabolism. The diversity and simplicity of conditions 23
that form thioesters from core metabolites suggests the energetic link between thioester 24
synthesis and catabolism was in place at the earliest stage of prebiotic chemistry, 25
constraining the path for the later evolution of life’s phosphorus-based energy currencies. 26
A major goal of origins of life research is to understand how and why chemistry self-27
organized into today’s biochemistry.1,2,3 The recent discovery of chemical reaction networks that 28
break or form bonds in ways closely resembling biochemistry suggests that core metabolic 29
pathways emerged from simpler non-enzymatic precursors, providing a straightforward 30
explanation for why biochemistry came to be the way it is.4,5,67,8,9,10 However, non-enzymatic 31
reaction networks that combine metabolite synthesis with life’s ability to capture chemical energy 32
from catabolic (breakdown) processes have yet to be demonstrated. 33
The hydrolysis of thioesters is highly exergonic, which allows them to occupy a central 34
position in biosynthesis and to act as life’s sulfur-based energy carriers.11 Accordingly, thioesters 35
are thought to have played a dominant role in early biochemical evolution – a concept that De 36
Duve dubbed the “Thioester World”.12,13,14 In biology, two of the main catabolic routes for 37
thioester synthesis are the oxidative decarboxylation of α-ketoacids and the oxidation of 38
aldehydes, both of which employ the thiol cofactor A (CoA), and which constitute key steps in 39
core metabolic pathways such as the Krebs cycle and glycolysis (Figure 1). Recent 40
computational predictions, based on the network structure and thermodynamics of all 41
documented metabolic reactions, also support the existence of an early metabolic network 42
hinging on thioesters.15,16 Specifically, acetyl, malonyl, malyl and succinyl thioesters were 43
predicted to emerge within or from a reaction network resembling a primitive (reverse) Krebs 44
cycle.16 Here we show that the same thioesters can be produced non-enzymatically from 45
biological α-ketoacids and integrated into a Krebs cycle-like chemical reaction network, in good 46
agreement with computational predictions about the structure of primitive metabolism.15,16 47
48
49
Figure 1 Energy conservation via thioesters in biosynthesis. A) Thioester synthesis in the Krebs 50 cycle. Oxidative decarboxylations of α-ketoacids are highlighted using red arrows. Additional 51 biological reactions, such as the aldol reaction of acetyl thioester with glyoxylate to give malyl 52 thioester, are also shown. A similar network was predicted to have been at the core of primitive 53 metabolism, by starting from simple seed molecules and applying a thermodynamically constrained 54 network expansion algorithm to grow the network using known biological reactions.16 B) Thioester 55 synthesis via aldehyde oxidation in alcohol metabolism and glycolysis. C) Nature’s most important 56 thiol, coenzyme A (CoA) and a simpler analogue used in this study, N-acetylcysteamine. 57
58
Experimental work on prebiotic thioester synthesis is limited, with the most important 59
examples arising from aldehydes17,18,19,20 or acetyl thioester synthesis from carbon monoxide and 60
methyl thiol in very low yields.21 Inspired by the synthetic organic chemistry literature,22,23 we 61
searched for simple aqueous inorganic conditions that might enable thioester synthesis from α-62
ketoacids and thiols. Our initial investigations focused on the reaction between pyruvate, the 63
prebiotically plausible biological precursor to sugars and several amino acids,4,5,6,24 and N-64
SHNH
NH
OH
Me MeO
PO
PO
O
P O-
O-O
HO
NN
NN
H2N
OO-
O
O-
O
O O
coenzyme A (CoA)
SHNH
Me
O
N-acetylcysteamine
-O
O
O
O-
O
-O
O O
O-
O
-O
O
O-
O
-O
O
O-
O-O O
OH
-O
O
SR
O
citrate
ADP, Pi
R-SH, ATP
oxaloacetate
succinate
succinyl-thioester
-O
O
SR
O-O O
OHcitryl-thioester
H2O
R-SH
Me
O
SR
Me
O
O-
O
pyruvate
acetyl-thioester
2 steps
A
B
Me
O
SR
acetyl-thioester
Me H
O
acetaldehydeOH
OP
O
OO
O
OH
OP
O
OO
O
S-enzymeNAD+ NADHR-SH HS-enzyme
NAD+ NADH
glyceraldehyde 3-phosphate
-O
O
OH O
SR
-O
O
O
H
glyoxylate
malyl-thioester
-O
O O
SR
malonyl-thioester
C
CO2ATP. ADP
Pi
NAD+, R-SH
NADH, H+, CO2
NAD+
R-SH
NADH/H+
CO2
3 steps
α-ketoglutarate
acetylcysteamine, a simpler, potentially ancestral,25 analogue of CoA. Optimization of oxidizing 65
agent, catalyst, and temperature (see Table S-1) converged on sulfate radical-generating 66
conditions identical to those reported to drive Krebs cycle-like breakdown of core metabolites5 67
(S2O82- as oxidant, FeS as catalyst, 70 °C), giving the corresponding acetyl thioester in 27% yield 68
(Table 1, entry 1, method A). The remaining material was found mostly to be unreacted pyruvate 69
and a small amount of acetate, according to GC-MS and NMR analysis (Table S-2). Thioester 70
synthesis could equally be carried out with another water-soluble thiol (Scheme S-3), or with a 71
disulfide instead of a thiol (entry 2, method A). Two other key intermediates of the Krebs cycle, α-72
ketoglutarate and oxaloacetate also underwent decarboxylative thioesterification to give the 73
corresponding succinyl thioester, an analogue of the biosynthetic precursor to many co-factors, 74
and malonyl thioester, an analogue of the precursor to biological fatty acid synthesis, respectively 75
(entries 3-4, method A). Malonyl thioester formation is accompanied by decarboxylation to give 76
acetyl thioester as a secondary product (entry 4). Malyl thioester was also formed under the 77
same conditions starting from 4-hydroxyketoglutarate (entry 5, method A). UV-A light, thought to 78
have constituted a significant portion of the solar spectrum on the early Earth,26 was equally able 79
to generate sulfate radicals from S2O82-, and therefore to deliver thioesters from α-ketoacids at 80
ambient temperature (entries 1-5, method B). Alternatively, UV-A light alone was found to trigger 81
thioester formation under acidic conditions (entries 1-5, method C). In this case however, the 82
reduced reactivity with disulfides suggests the mechanism is distinct from the light-triggered 83
reaction in the presence of S2O82- (entry 2, method C). The direct photochemical reaction was 84
found to be independent of the chemical nature of the acid (Table S-1), ruling out the 85
involvement of photogenerated sulfate radicals from bisulfate.27 Acetaldehyde, a representative 86
aldehyde, was also found to furnish acetyl thioester under thermal and photochemical sulfate 87
radical-forming conditions (entry 6, methods A-B), as well as under direct photochemical 88
conditions similar to those previously reported by Weber (entry 6, method C).17 Thus, all three 89
sets of conditions are able to generate thioesters from both α-ketoacids and aldehydes. 90
Table 1. Thioester formation from biological α-ketoacids or aldehydes and N-acetylcysteamine.
Entry Substrate Thioester Product(s) Product Yield (%) ± SD ‡
Method Aa Method Bb Method Cc
1 pyruvate acetyl thioester 27 ± 1 31.2 ± 0.4 22.1 ± 0.4
2d pyruvate acetyl thioester 34 ± 1 32 ± 2 4.9 ± 0.2
3 α-ketoglutarate succinyl thioester 10 ± 2 25 ± 2 13 ± 1
4 oxaloacetate malonyl thioester 6.7 ± 0.4 24 ± 2 8 ± 2
acetyl thioester 2.6 ± 0.3 2.4 ± 0.3 < 0.5
5 hydroxyketoglutaratee malyl thioester 2.0 ± 0.1 10 ± 1 3.5 ± 0.2
6 acetaldehydef acetyl thioester 15 ± 1 13 ± 2 20 ± 2
‡ Reported values were determined by GC-FID after an extraction procedure or by LCMS and represent the average of at least three runs. SD = standard deviation. See the Supplementary Information for additional control experiments. Unless otherwise noted, 0.5 mmol of the substrate and 0.1 mmol of the thio compound were employed. aMethod A: K2S2O8 (2.0 equiv), FeS (0.5 equiv) in H2O, 3 h, 70 °C. bMethod B: K2S2O8 (2.0 equiv), FeS (0.5 equiv) in H2O, 6 h, UV-A. cMethod C: KHSO4 (3 M) in H2O, 6 h, UV-A. d0.05 mmol of N-acetyl cysteamine disulfide was used instead of N-acetyl cysteamine. eHydroxyketoglutarate was freshly prepared from glyoxylate and oxaloacetate without isolation. f1.0 mmol of the substrate were used.
91
We recently reported an iron-promoted non-enzymatic reaction network in which most 92
Krebs cycle metabolites are formed from pyruvate and glyoxylate, including other α-ketoacids.8 93
To mimic the biological integration of α-ketoacid synthesis, α-ketoacid breakdown and thioester 94
synthesis, we simulated non-equilibrium environments where material could cycle between 95
neutral and oxidized regions, or between dark and light regions. In a first experiment, pyruvate, 96
glyoxylate, ferrous iron and N-acetylcysteamine were mixed in water at 70 °C for 1 h, after which 97
time K2S2O8 was added and the reaction continued without changing the temperature. At 4 h, 98
acetyl (1.4 mM), succinyl (0.1 mM) and malyl (3.6 mM) thioesters were detected, as well as 8 99
carboxylic acid metabolites (Table S-3). In a second experiment, pyruvate, glyoxylate and 100
ferrous iron were mixed in water at 70 °C for 1 h, after which time N-acetylcysteamine and 101
KHSO4 were added and the reaction was exposed to UV-A light at 22 °C. At 7 h, acetyl (0.1 mM), 102
succinyl (0.2 mM) and malyl (0.06 mM) thioesters were detected, as well as 5 carboxylic acid 103
metabolites (Table S-3). Thus, different types of non-equilibrium environments (neutral/oxidized 104
or dark/light) can lead to a non-enzymatic reaction network in which α-ketoacid and thioester 105
synthesis are coupled, as in biochemistry (Figure 2). 106
107
108 109 Figure 2 Thioester formation from an iron-catalysed reaction network generated from pyruvate, 110 glyoxylate and N-acetylcysteamine, achieved through redox or light cycling. Molecules in black 111 represent those observed in the presence of Fe2+, thiol and oxidant. Molecules in grey represent 112 those observed in the presence of Fe2+ only. Additional reactions and observed metabolites have 113 been omitted for clarity. 114
115
In summary, inorganic oxidants or light enable non-enzymatic thioester synthesis from 116
metabolites in a way that closely mimics energy conservation within biological catabolism, and 117
that is integrated with metabolite-generating chemical networks. Synthesis and breakdown of 118
metabolites could have been linked in an energy-conserving way from the outset of prebiotic 119
chemistry, in accord with computational models of an “onion-like” growth of metabolism from one 120
initially based on C, H, and O to one incorporating S, N, and then P.12,13,15,16 The simplicity of the 121
conditions observed here suggest thioester synthesis would have been difficult to avoid in any 122
near-surface environment where light, α-ketoacids or aldehydes and thiols were present. A 123
primitive form of bioenergetics built around thioesters therefore may have emerged very early on, 124
setting the stage for the complex life-like behaviours characteristic of thioester networks,28,29 and 125
imposing constraints on later chemical energy currencies based on phosphorous. Finally, 126
Me
O
O-
OO
O-
O
-O
O
OH
O-
O
-O
O
O-
O
-O
O
O-
O
-O
O
OH
-O
O
O-
OO-OO
-O
O
O-
O-
O2C OH
O
-O
O
O-
O
O
O-
O
-O
O
O
O-
O
OH-O
Me O-
O
OO
O-
O
OO
O-
OO
O-
acetate
pyruvate
oxaloacetate
malate
fumarate
succinate
α-ketoglutarate isocitrate
glyoxylate
glyoxylate
glyoxylate
oxalohydroxyglutarate
oxopentenedioate
hydroxyketoglutarate
O
O-
O
-O
malonate
input
SR
O
-O
O
Decarboxylative thioesterification (-CO2 - 2e- - H+ + RSH)
Hydrolysis (+H2O - RSH)
Me SR
O O
-O
O
SR
acetyl thioester malonyl thioester
succinyl thioester
SR
OOH-O
Omalyl thioester
input
hydrogen-rich geochemical environments where reductive metabolite synthesis6 could occur 127
within proximity of oxidants or light, such as surface hydrothermal vents, warrant consideration 128
for the origin of life.30 129
130
Funding: This project has received funding from the European Research Council (ERC) under 131
the European Union's Horizon 2020 research and innovation programme (grant agreement n° 132
639170) and from ANR LabEx “Chemistry of Complex Systems” (ANR-10-LABX-0026 CSC). 133
Acknowledgements: J.-L. Schmitt and C. Antheaume are gratefully acknowledged for 134
assistance with LC-MS and GC experiments. We also thank M. Coppe for help with the NMR 135
experiments. 136
Author contributions: J.M. supervised the research and the other authors performed the 137
experiments. All authors contributed intellectually throughout the study. All authors wrote the 138
paper and E.C.-B. and J.G. assembled the Supplementary information. 139
Competing financial interests: Authors declare no competing financial interests. 140
Data and materials availability: All data is available in the main text or the supplementary 141
information file. 142
Supplementary Information: 143
Materials and Methods 144
Figures S-1 to S-9 145
Tables S-1 to S-3 146
Scheme S-1 to S-4 147
References 148
1 G Wächtershäuser, Evolution of the first metabolic cycles, Proceedings of the National
Academy of Sciences 87, 200–204 (1990).
2 E. Smith & H. J. Morowitz, Universality in intermediary metabolism, Proceedings of the National
Academy of Sciences of the United States of America 101, 13168–13173 (2004).
3 W. F. Martin & M. J. Russell, On the origin of biochemistry at an alkaline hydrothermal vent.
Philosophical Transactions of the Royal Society B 362, 1887–1925 (2007).
4 S. J. Varma, K. B. Muchowska, P. Chatelain & J. Moran, Native iron reduces CO2 to
intermediates and end-products of the acetyl-CoA pathway, Nature Ecology & Evolution 2, 1019–
1024 (2018).
5 A Roldan et al., Bio-inspired CO2 conversion by iron sulfide catalysts under sustainable
conditions, Chemical Communications 51, 7501–7504 (2015).
6 M. Preiner et al. A hydrogen dependent geochemical analogue of primordial carbon and energy
metabolism. BioRxiv doi: 10.1101/682955 (2019).
7 M. A. Keller, D. Kampjut, S. A. Harrison & M. Ralser, Sulfate radicals enable a non-enzymatic
Krebs cycle precursor, Nature Ecology & Evolution 1, 0083 (2017).
8 K. B Muchowska, S. J. Varma, & J. Moran, Synthesis and breakdown of universal metabolic
precursors promoted by iron, Nature 569, 104–107 (2019).
9 K. B. Muchowska et al., Metals promote sequences of the reverse Krebs cycle, Nature Ecology
& Evolution 1, 1716–1721 (2017).
10 M. Keller, A. Turchyn & M. Ralser, Non-enzymatic glycolysis and pentose phosphate pathway-
like reactions in a plausible Archean ocean, Mol Syst Biol 10, 725–725 (2014).
11 Biochemistry: The Chemical Reactions of Living Cells, David E. Metzler, Volume 1, Second
Edition
12 De Duve, C. Blueprint for a cell: The nature and origin of life. (Neil Patterson Publishers,
1991).
13 H. Hartman, Speculations on the origin and evolution of metabolism, Journal of Molecular
Evolution 4, 359–370 (1975)
14 D. Deamer, A. L. Weber, Bioenergetics and life’s origin. Cold Spring Harb Perspect Biol 2,
a004929 (2010).
15 J. E. Goldford, H. Hartman, T. F. Smith & D. Segrè, Remnants of an Ancient Metabolism
without Phosphate, Cell 168, 1126–1134 (2017).
16 J. E. Goldford, H. Hartman, R. Marsland III & D. Segrè, Boundary conditions for early life
converge to an organo-sulfur metabolism, bioRxiv, doi: 10.1101/487660
17 A. L. Weber, Prebiotic formation of “energy-rich” thioesters from glyceraldehyde and N-
acetylcysteine. Orig. Life. Evol Biosph. 15, 17-27 (1984).
18 M. Takagi, S. Goto, T. Matsuda, Photo-reaction of lipoic acid and related organic disulphides:
reductive acylation of aldehydes, J. Chem. Soc. Chem. Commun. 92-93 (1976).
19 A. L. Weber, Prebiotic amino acid thioester synthesis: thiol-dependent amino acid synthesis from
formose substrates and ammonia. Orig. Life Evol. Biospheres 28, 259-270 (1998).
20 A. L. Weber, Nonenzymatic formation of “energy-rich” lactoyl and glyceroyl thioesters from
glyceraldehyde and a thiol. J. Mol. Evol. 20, 157-166 (1984).
21 C. Huber, G. Wächtershäuser, Activated acetic acid by carbon fixation on (Fe,Ni)S under
primordial conditions. Science 276, 245-247 (1997).
22 G. Rong, J. Mao, D. Liu, H. Yan, Y. Zheng, J. Chen, Formation of C(sp2)-S bonds through
decarboxylation of α-oxocarboxylic acids with disulfides or thiophenols, RSC Adv. 5, 26461–
26464 (2015).
23 K. Yan, D. Yang, W. Wei, J. Zhao, Y. Shuai, L. Tian, H. Wang, Catalyst-free direct
decarboxylative coupling of α-keto acids with thiols: a facile access to thioesters, Org. Biomol.
Chem. 13, 7323–7330 (2015).
24 Coggins, A. & Powner, M. Prebiotic synthesis of phosphoenol pyruvate by α-phosphorylation-
controlled triose glycolysis. Nat Chem 9, 310–317 (2016).
25 Atomi, H., Tomita, H., Ishibara, T., Yokooji, Y., Imanaka, T. CoA biosynthesis in archea.
Biochem. Soc. Trans. 41, 427-431 (2013).
26 P. A. Karam, Inconstant sun: how solar evolution has affected cosmic and ultraviolet radiation
exposure over the history of life on Earth, Health Phys. 84, 322–333 (2003).
27 J. Barrett, M. F. Fox, A. L. Mansell, The photochemistry of aqueous sulfate ion, J. Phys. Chem.
69, 2996–3000 (1965).
28 S. N Semenov et al. Autocatalytic, bistable, oscillatory networks of biologically relevant organic
reactions, Nature 537, 656–660 (2016).
29 H. Jakubowski, Homocysteine Editing, Thioester Chemistry, Coenzyme A, and the Origin of
Coded Peptide Synthesis, Life 7, 6 (2017).
30 P. B. Rimmer; O. Shorttle, Origin of life’s building blocks in carbon- and nitrogen-rich surface
hydrothermal vents, Life 9, 12 (2019).
download fileview on ChemRxivthioesters v14.pdf (220.89 KiB)
S1
Supporting Information
Energy conservation via thioesters in a non-enzymatic
metabolism-like reaction network
Elodie Chevallot-Beroux,‡ Jan Gorges,
‡ Joseph Moran*
Université de Strasbourg, CNRS, ISIS UMR 7006, F-67000 Strasbourg, France
[email protected], ‡these authors contributed equally to this work
S2
Content
1. General information ........................................................................................................................ 3
2. Analytical methods .......................................................................................................................... 5
2.1. GC-FID analysis .................................................................................................................... 5
2.2. LCMS analysis ...................................................................................................................... 7
2.3. GC-MS analysis .................................................................................................................. 11
2.4. NMR analysis with water suppression ................................................................................ 11
3. Synthetic procedures ..................................................................................................................... 12
3.1. Synthesis of starting materials ............................................................................................. 13
3.2. Synthesis of reference compounds ...................................................................................... 16
3.3. Formation of thioesters under prebiotic conditions ............................................................. 21
3.4 Thioester formation from a non-enzymatic reaction network ............................................. 27
4. Experimental data .......................................................................................................................... 29
4.1. NMR spectra of the synthesized compounds ...................................................................... 29
4.2. NMR spectra of reference compds. in H2O/D2O with DSS as IS with water suppression .. 40
4.3. NMR spectra of selected reaction mixtures showing prebiotic thioester formations .......... 48
4.4. GC-FID chromatograms of authentic samples .................................................................... 57
4.5. GC-FID chromatograms of the prebiotic thioester formation ............................................. 60
4.6. GC-FID chromatograms of the network combined with thioester formation ..................... 68
4.7. LC-MS chromatograms of authentic samples ..................................................................... 70
4.8. LC-MS chromatograms of thioester formation under prebiotic conditions ........................ 76
4.9. LC-MS chromatograms of the network combined with thioester formation ...................... 82
4.10. GC-MS chromatograms of authentic samples ..................................................................... 85
4.11. GC-MS chromatograms of the network after thioester formation ...................................... 86
5. Supporting references .................................................................................................................... 92
S3
1. General information
All reactions were carried out in oven dried glassware under an atmosphere of argon. All glassware
and stir bars were pre-washed with acid, followed by distilled water and acetone, and oven dried to
prevent any cross-contamination by metal salts. Unless otherwise noted, all reagents and solvents were
purchased from commercial suppliers and used without further purification. Water was obtained from
a Milli-Q purification system (18 MΩcm) and was purged with argon before use.
For water suppression 1H-NMR spectra were recorded on a Bruker Avance300 (300 MHz)
spectrometer at ambient temperature in a H2O:D2O mixture (6:1) as solvent, with sodium 3-
(trimethylsilyl)-1-propanesulfonate (DSS) as the internal standard (TMS peak at 0 ppm). Solvent
suppression was achieved through excitation sculpting, using the Bruker ZGESGP pulse program
adjusted for the water resonance. Integration was performed using ACD/NMR Processor Academic
Version 12.00 software.
Regular 1H- and
13C-NMR spectra were recorded on a Bruker Avance300 (300 MHz), Bruker
UltraShield 400 (400 MHz) or a Bruker Avance 500 (500 MHz) spectrometer at ambient temperature
and are reported in ppm using the solvent signal as internal reference (CDCl3 at 7.26 ppm (1H) or
77.00 ppm (13
C), DMSO-d6 at 2.50 ppm (1H) or 39.51 ppm (
13C)). Data are reported as: multiplicity
(br. s = broad singlet, s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet), coupling
constants (in Hz) and integration. Melting points were obtained on a Büchi Melting Point B-450
apparatus without correction. High resolution mass spectrometry (HRMS) analysis was performed on
a Bruker MicroTOF-Q (ESI) instrument.
LC-MS analysis was performed on a ThermoFisher Scientific UltiMate 3000 UHPLC-system
equipped with an C18 ThermoFisher Hypersil Gold 10 mm column using an Exactive Plus EMR
Orbitrap detector. Acetonitrile (+ 0.1 % formic acid) and water (+ 0.1 % formic acid) were used for
the mobile phase. The column was maintained at 25 °C and the solvent gradient was used as
following: 2% MeCN for 1 min, linear gradient to 15% MeCN over 3.5 min, linear gradient to 100%
MeCN over 1 min, 100% MeCN for 2.5 min, linear gradient to 2% MeCN over 0.5 min, 2% MeCN
for 1.5 min. The analytes were quantified using a calibration of authentic samples by integration of the
peak area of a specified m/z range. Unless otherwise noted 0.1 µL of the sample solutions were
injected.
GC-MS analysis was performed on a GC System 7820A (G4320) using an Agilent High Resolution
Gas Chromatography Column (PN 19091S – 433UI, HP – 5MS UI, 28 m×0.250 mm, 0.25 Micron, SN
USD 489634H). The system was connected to an MSD block 5977E (G7036A). Hydrogen (99.999 %
purity) was used as carrier gas at a constant flow rate of 1.5 mL/min. The analysis was carried out in a
splitless mode with 1 μL injection volume, at the injection port temperature of 250 °C. The column
was maintained at 60 °C for 1 min, then ramped at 30 °C/min to 310 °C with 3 min hold, and the total
S4
running time was 12.33 min. The mass spectrometer was turned on after a 2-min solvent delay, and
was operated at the electron ionization (EI) mode with quadrupole temperature of 150 °C. Data was
acquired in the full-scan mode (50-500 amu).
GC-FID analysis was performed on a GC System GC7890B with an FID-detector using an Agilent
High Resolution Gas Chromatography Column (PN 19091S – 433UI, HP – 5MS UI, 28 m×0.250 mm,
0.25 Micron, SN USD 489634H). Hydrogen (99.999 % purity) was used as carrier gas at a constant
flow rate of 5.0 mL/min. The analysis was carried out in a splitless mode with 1 μL injection volume,
at the injection port temperature of 250 °C. The column was maintained at 60 °C for 1 min, then
ramped at 30 °C/min to 300 °C with 3 min hold, and the total running time was 12 min. The FID
detector was used with an airflow of 400 mL/min, a H2 fuel flow of 25 mL/min and a N2 makeup flow
of 10 mL/min. The software used was Agilent OpenLAB CDS ChemStation Edition Rev.
C.01.09[144].
S5
2. Analytical methods
2.1. GC-FID analysis
Extraction procedure for GC-FID analysis
A 0.5 mL aliquot of the reaction mixture was added to 0.5 mL of EA, followed by vortexing for 30 s.
The EA layer was separated and dried over anhydrous Na2SO4. 40 µL of the dry EA layer was diluted
with 960 µL of EA and subjected to GC-FID analysis.
Yield determination and error analysis for GC-FID analysis
1 mL standard aqueous solutions of thioesters at different concentrations (1 mM, 2 mM, 5 mM, 10
mM, 20 mM, 40 mM) were prepared by dilution 100 mM stock solutions of these thioesters. 500 µL
of each standard solution were extracted using the above described extraction procedure for GC-FID
analysis. For each thioester, a six-point graph was plotted, correlating the characteristic GC peak (as
integrated automatically by the Agilent OpenLAB CDS ChemStation Edition Rev. C.01.09[144]
software) with substrate concentration (Figure S-1 – S-2). Each data point was obtained from three
independent measurements and the correlation line was obtained from the least-squares fitting
(intercept = 0). Error bars on graphs are shown as ± standard deviation for each data point. Overall
percentage error of the response factor corresponds to ± standard deviation for each slope value.
The concentrations of the compounds were calculated by comparing the product peak area with the
calibration curve. The yields of the products were calculated by multiplication of the determined
concentration with the reaction volume, divided by the amount of limiting starting material (in most
cases 0.1 mmol of the thio compound). Each reaction was performed at least three times to ensure
reproducibility and reported percentage yields are an average of these three runs, with an error
corresponding to ± standard deviation.
S6
Figure S-1: Correlation between the concentration of an aqueous solution of 3b and the measured gas
chromatography FID peak area.
Figure S-2: Correlation between the concentration of an aqueous solution of 3c and the measured gas
chromatography FID peak area.
R² = 0,9984
0
100
200
300
400
500
600
0 10 20 30 40 50
Pe
ak
are
a,
pA
*s
Concentration, mmol/L
R² = 0,9998
0
200
400
600
800
1000
1200
1400
0 10 20 30 40 50
Pe
ak
are
a,
pA
*s
Concentration, mmol/L
N,S-diacetyl cysteamine (3b)
Response factor: 11.773
S-(2-(2-(2-methoxyethoxy)ethoxy)ethyl)
ethanethioate (3c)
Response factor: 31.655
S7
2.2. LCMS analysis
Sample preparation of LCMS analysis
After treatment of 1 mL of the reaction mixture with Chelex® 100 resin followed by centrifugation 20
µL of the supernatant were diluted with 180 µL of MilliQ-water and subjected to LCMS analysis
(injection volume = 0.1 µL unless otherwise noted).
Yield determination and error analysis for LCMS analysis
1 mL standard aqueous solutions of authentic samples at different concentrations (selection of 0.5
mM, 1 mM, 2 mM, 4 mM, 5 mM, 10 mM, 20 mM, 40 mM, 80 mM) were prepared by dilution of 100
mM stock solutions of these compounds. For each of these solutions 20 µL were diluted with 180 µL
MilliQ-water and subjected to LCMS-analysis. For each compound, a six-point graph was plotted,
correlating the characteristic LCMS-peak (as integrated by the Thermo Xcalibur 4.2.28.14 Qual
Browser software) with substrate concentration (Figure S-3 – S-7). Each data point was obtained from
three independent measurements and the correlation line was obtained from the least-squares fitting
(intercept = 0). Error bars on graphs are shown as ± standard deviation for each data point. Overall
percentage error of the response factor corresponds to ± standard deviation for each slope value.
The concentrations of the compounds were calculated by comparing the product peak area with the
calibration curve. The yields of the products were calculated by multiplication of the determined
concentration with the reaction volume, divided by the amount of limiting starting material (in most
cases 0.1 mmol of the thio compound). Each reaction was performed at least three times to ensure
reproducibility, and reported percentage yields are an average of these three runs, with an error
corresponding to ± standard deviation.
Figure S-3: Correlation between the concentration of an aqueous solution of 5b and the measured
LCMS peak area (m/z = 219.95–220.15).
y = 3,95597E+07x
R² = 0,9988
0,00E+00
5,00E+08
1,00E+09
1,50E+09
2,00E+09
2,50E+09
3,00E+09
3,50E+09
0 20 40 60 80 100
Pe
ak
Are
a (
m/z
= 2
19
.95
-22
0.1
5)
Concentration, mmol/L
4-[[2-(Acetylamino)ethyl]thio]-4-
oxobutanoic acid (5b)
Response factor: 3.95597*10^7
S8
Figure S-4: Correlation between the concentration of an aqueous solution of 8b and the measured
LCMS peak area (m/z = 205.54–206.54).
Figure S-5: Correlation between the concentration of an aqueous solution of 9b and the measured
LCMS peak area (m/z = 236.04–236.06).
y = 3,64713E+07x
R² = 0,9950
0,00E+00
2,00E+08
4,00E+08
6,00E+08
8,00E+08
1,00E+09
1,20E+09
1,40E+09
1,60E+09
0 10 20 30 40 50
Pe
ak
Are
a (
m/z
= 2
05
.54
-20
6.5
4)
Concentration, mmol/L
y = 1,08917E+07x
R² = 0,9997
0,00E+00
5,00E+07
1,00E+08
1,50E+08
2,00E+08
2,50E+08
0 5 10 15 20 25
Pe
ak
Are
a (
23
6.0
4-2
36
.06
)
Concentration, mmol/L
3-((2-acetamidoethyl)thio)-3-
oxopropanoic acid (8b)
Response factor: 3.64713*10^7
4-((2-acetamidoethyl)thio)-2-hydroxy-4-
oxobutanoic acid (9b)
Response factor: 1.08917*10^7
S9
Figure S-6: Correlation between the concentration of an aqueous solution of 1b and the measured
LCMS peak area (m/z = 119.95–120.15).
Figure S-7: Correlation between the concentration of an aqueous solution of 1d and the measured
LCMS peak area (m/z = 236.97–237.17).
y = 2,55663E+07x
R² = 0,9973
0,00E+00
5,00E+08
1,00E+09
1,50E+09
2,00E+09
2,50E+09
0 20 40 60 80 100
Pe
ak
Are
a (
m/z
= 1
19
.95
-12
0.1
5)
Concentration, mmol/L
y = 8,26212E+07x
R² = 0,9927
0,00E+00
5,00E+08
1,00E+09
1,50E+09
2,00E+09
2,50E+09
3,00E+09
3,50E+09
4,00E+09
0 10 20 30 40 50
Pe
ak
Are
a (
m/z
= 2
36
.97
-23
7.1
7)
Concentration (mmol/L)
N,N'-(disulfanediylbis(ethane-2,1-
diyl))diacetamide (1d)
Response factor: 8.26212*10^7
N -acetylcysteamine (1b)
Response factor: 2.55663*10^7
S10
Figure S-8: Correlation between the concentration of an aqueous solution of 3b and the measured
LCMS peak area (m/z = 161.95–161.15).
y = 5,72370E+07x
R² = 0,99995
0,00E+00
1,00E+09
2,00E+09
3,00E+09
4,00E+09
5,00E+09
0 20 40 60 80 100
Pe
ak
Are
a (
m/z
= 1
61
.95
-16
2.1
5)
Concentration, mmol/L
N,S-diacetylcysteamine (3b)
Response factor: 5.72370*10^7
S11
2.3. GC-MS analysis
Derivatisation procedure for GC-MS analysis
To facilitate GC-MS analysis, a literature ECF-derivatization procedure1,2
was applied to the sample to
convert carboxy groups to ethyl esters, hydroxy groups to ethyl carbonates, ketones to diethyl ketals,
and aldehydes to diethyl acetals, using a mixture of ethanol/ethyl chloroformate (EtOH/ECF). For
optimal gas chromatography resolution, heavy metal atoms were first removed using a resin (Chelex®
100 sodium form).
A ca. 1 mL aliquot of the reaction mixture was added to 50 mg of Chelex®, briefly shaken and then
centrifuged (6000 rpm, 3 min). To 600 µL of the supernatant was added EtOH (300 µL) and pyridine
(40 µL), followed by ethyl chloroformate (ECF, 40 µL). The mixture vortexed for 30 s. A second 40
µL portion of ECF was added and the mixture was vortexed again for 30 s. Next, CHCl3 (200 µL) was
added, followed by vortexing (10 s). Finally, NaHCO3 (600 µL) was added and the mixture was
vortexed again for 10 s. The CHCl3 layer was separated and dried over anhydrous Na2SO4. 50 µL of
the dry CHCl3 layer were diluted with 150 µL of ethyl acetate prior to GC-MS analysis.
Product identification
Reaction products derivatized were identified by comparing the mass spectra and retention times with
analogously derivatized authentic samples, as described in a previous paper.3
2.4. NMR analysis with water suppression
For 1H-NMR analysis using water suppression the samples were first treated with Chelex® 100 resin
followed by centrifugation to remove heavy metal ions. 600 µL from the supernatant were mixed with
100 µL of DSS in D2O (0.05 M) and analyzed by NMR with water suppression. Water suppression
was achieved using the Bruker ZGESGP pulse program. Relaxation delay D1 was set to 87 s, with
time domain size TD = 32768 and sweep width SWH = 4789.27 Hz (11.963 ppm). 32 scans were
acquired for each sample.
S12
3. Synthetic procedures
Compound Structure New Lit 1H
13C GC-
FID
HRMS
10
No 4 + - - -
1c
No 5 + + + -
1d
NH
3
4
S21
O
S
HN
O
No 6 + + + -
3b
No 7 + + + -
3c
No 8 + + + -
5b
No 9 + + - -
11 Yes - + + + +
8b
O
23
O
76S
4
5
NH
1HO
O
No 10
+ + - -
12
No 11
+ + - -
13
Yes - + + - +
9b
Yes - + + - +
S13
3.1. Synthesis of starting materials
Scheme S- 1: Synthesis routes toward 1d and 1c.
N,N'-(disulfanediylbis(ethane-2,1-diyl))diacetamide (1d)6
NH
3
4
S21
O
S
HN
O To a solution of N-acetylcysteamine 1b (1.00 g, 8.39 mmol,
1.0 equiv) in 9 mL of EA was added potassium iodide (7.0 mg, 0.042 mmol, 0.5 mol%) and aqueous
hydrogen peroxide (33 wt.%, 857 µL, 9.23 mmol, 1.1 equiv) subsequently and the mixture was stirred
at room temperature. After one hour the resulting brown solution was treated with Na2S2O3-solution (5
wt.%, 10 mL) followed by further stirring for 5 minutes. Then the layers were separated, and the
aqueous layer was extracted two more times with EA (2 x 20 mL). The combined organic layers were
dried (Na2SO4) and filtered. The solvent of the filtrate was removed in vacuo which gave access to 1d
(653 mg, 2.76 mmol, 66%) as a colorless white powder.
m.p. 87–88°C 1H-NMR (500 MHz, CDCl3): δ = 2.03 (s, 6 H, 1-H), 2.83 (t,
3J4,3 = 6.6 Hz, 4 H, 4-H),
3.56 (dt, 3J3,4 ≈
3J3,NH = 6.4 Hz, 4 H, 3-H), 6.68 (bs, 2 H, N-H).
13C-NMR (125 MHz, CDCl3): δ =
23.1, 37.7, 38.6, 170.9.
S14
2-(2-(2-methoxyethoxy)ethoxy)ethyl 4-methylbenzenesulfonate (10)4
For the synthesis of the tosylate to a solution of
triethylene glycol monomethyl ether (12.3 g, 75 mmol, 1.0 equiv) in 150 mL DCM was added
triethylamine (11.5 mL, 82 mmol, 1.1 equiv), 4-dimethylaminopyridine (0.46 g, 3.75 mmol, 5 mol%)
and tosyl chloride (14.3 g, 75 mmol, 1.0 equiv). After stirring the reaction mixture for 5 hours at room
temperature DCM (100 mL) was added and the organic layer was washed with 1 M HCl solution (150
mL). The layers were separated, and the organic layer was dried (Na2SO4) and filtered. After removal
of the solvent in vacuo the crude tosylate 10 (21.9 g) was isolated as a yellow oil and used in the next
step without further purification.
1H-NMR (400 MHz, CDCl3): δ = 2.44 (s, 3 H, 12-H), 3.36 (s, 3 H, 1-H), 3.53 (m, 2 H, 2-H),
3.56–3.63 (m, 6 H, 3-H, 4-H, 5-H), 3.68 (t, 3J6,7 = 4.8 Hz, 2 H, 6-H), 4.15 (t,
3J7,6 = 4.8 Hz, 2
H, 7-H), 7.33 (d, 3J10,9 = 8.1 Hz, 2 H, 10-H), 7.79 (d,
3J9,10 = 8.2 Hz, 2 H, 9-H).
S-(2-(2-(2-methoxyethoxy)ethoxy)ethyl) ethanethioate (3c)8
To a solution of the tosylate 10 (21.9 g, 68.7 mmol, 1.0 equiv)
in 100 mL DMF under N2-atmosphere was added potassium iodide (0.57 g, 3.44 mmol, 5 mol%) and
potassium thioacetate (9.42 g, 82 mmol, 1.2 equiv). The mixture was stirred at room temperature
overnight. After 16 hours 300 mL of EA were added followed by washing with water (3 x 150 mL).
The organic layer was dried (Na2SO4) and filtered. After removal of the solvent in vacuo the thioester
3c (10.9 g, 49.2 mmol, 66% over two steps) was isolated as a yellow oil. The compound was used for
the synthesis of 1c and also as an authentic sample for the acetylation reaction.
1H-NMR (400 MHz, CDCl3): δ = 2.32 (s, 3 H, 9-H), 3.08 (t,
3J7,6 = 6.5 Hz, 2 H, 7-H), 3.37 (s, 3 H, 1-
H), 3.54 (m, 2 H, 2-H), 3.56–3.66 (m, 8 H, 3-H, 4-H, 5-H, 6-H). 13
C-NMR (100 MHz, CDCl3): δ =
28.8, 30.5, 59.0, 69.7, 70.3, 70.5, 70.5, 71.9, 195.5.
S15
2-(2-(2-methoxyethoxy)ethoxy)ethane-1-thiol (1c)5
For the synthesis of the thiol to a slurry of potassium
carbonate (9.33 g, 67.5 mmol, 1.5 equiv) in 45 mL of methanol was added a solution of 3c (10.0 g, 45
mmol, 1.0 equiv) dropwise over 30 seconds in the dark. After stirring at room temperature for one
hour the reaction mixture was diluted with DCM (300 mL) and washed with sat. NH4Cl solution. The
aqueous layer was extracted with DCM (100 mL) and the combined organic layers were dried
(Na2SO4). After filtration the solvent was removed under reduced pressure giving access to 1c (7.75 g,
43 mmol, 96%) as a pale yellow oil.
1H-NMR (400 MHz, CDCl3): δ = 1.57 (t,
3JSH,7 = 8.3 Hz, 1 H, S-H), 2.68 (dt,
3J7,SH = 8.3 Hz,
3J7,6 =
6.4 Hz, 2 H, 7-H), 3.37 (s, 3 H, 1-H), 3.50–3.68 (m, 10 H, 2-H, 3-H, 4-H, 5-H, 6-H). 13
C-NMR (100
MHz, CDCl3): δ = 24.3, 59.0, 70.2, 70.6, 70.6, 71.9, 72.9.
S16
3.2. Synthesis of reference compounds
Scheme S- 2: Synthesis routes toward several reference compounds.
S17
N,S-diacetyl cysteamine (3b)7
To a solution of N-acetyl cysteamine 1b (2.00 g, 16.8 mmol, 1.0 equiv) in 50
mL of DCM was added DIPEA (4.4 mL, 25.2 mmol, 1.5 equiv) followed by the dropwise addition of
acetyl chloride (1.2 mL, 17.6 mmol, 1.05 equiv). The reaction mixture was stirred at room
temperature. After 1.5 hours the mixture was diluted with DCM (50 mL) and washed with 1 M HCl
solution (30 mL) and sat. NaHCO3-solution (10 mL). The organic layer was dried (Na2SO4) and
filtered. Removal of the solvent under reduced pressure afforded 3b (2.00 g, 12.4 mmol, 74%) as a
pale yellow oil.
1H-NMR (300 MHz, CDCl3): δ = 1.95 (s, 3 H, 1-H), 2.34 (s, 3 H, 6-H), 3.00 (t,
3J4,3 = 6.5 Hz, 2 H, 4-
H), 3.40 (dt, 3J3,4 ≈
3J3,NH = 6.3 Hz, 2 H, 3-H), 6.03 (br. s, 1 H, N-H).
13C-NMR (75 MHz, CDCl3): δ =
23.1, 28.7, 30.6, 39.5, 170.4, 196.3.
4-[[2-(Acetylamino)ethyl]thio]-4-oxobutanoic acid (5b)9
To a solution of N-acetyl cysteamine 1b (99.2 mg, 0.83 mmol,
1.0 equiv) in 3 mL of acetonitrile was added DMAP (10.2 mg, 0.083 mmol, 0.1 equiv), pyridine
(197.4 mg, 2.50 mmol, 3.0 equiv) and succinic anhydride (83.26 mg, 0.83 mmol, 1.0 equiv). The
reaction mixture was stirred at room temperature. After 2 hours the mixture was diluted with sat.
NaHCO3-solution (3 mL) and washed with Et2O (5 mL). The organic layer was discarded. The
aqueous layer was acidified with 1 M HCl solution to pH 1 and was extracted with EA (4 × 10 mL).
The combined organic layers were dried (Na2SO4). After filtration the solvent was removed under
reduced pressure giving access to 5b (88 mg, 0.40 mmol, 48 %) as a colorless powder.
m.p. 78–80 °C 1H-NMR (500 MHz, CDCl3): δ = 1.97 (s, 3 H, 8-H), 2.73 (t,
3J3,2 = 6.6 Hz, 2 H, 3-H),
2.90 (t, 3J2,3 = 6.6 Hz, 2 H, 2-H), 3.06 (t,
3J5,6 = 6.2 Hz, 2 H, 5-H), 3.45 (dt,
3J6,5 =
3J6,N-H = 6.2 Hz, 2 H,
6-H), 5.99 (s, 1 H, N-H). 13
C-NMR (125 MHz, CDCl3): δ = 23.1, 28.5, 28.9, 38.3, 39.7, 171.0, 175.5,
198.5.
S18
3-((2-acetamidoethyl)thio)-3-oxopropanoic acid (8b)10
O
23
O
76S
4
5
NH
1HO
O To a solution of malonyl monothiophenylester12
(125 mg, 0.64 mmol,
1.0 equiv) and NaHCO3 (107 mg, 1.27 mmol, 2.0 equiv) in 1 mL of MilliQ water was added N-
acetylcysteamine 1b (85 mg, 0.71 mmol, 1.1 equiv) dissolved in 1 mL of MilliQ water over 30
minutes. After stirring at room temperature for one hour, the mixture was acidified to pH = 1 with 1 M
HCl. The aqueous layer was washed with chloroform (3 x 10 mL) and DCM (2 x 10 mL). The
aqueous layer was lyophilizd. The resulting solid was suspended in acetonitrile (20 mL) and filtered to
remove NaCl. The filtrate was dried in vacuo giving access to the malonyl thioester 8b (80 mg, 0.39
mmol, 61 %) as a pale yellow oil.
1H-NMR (500 MHz, CDCl3, DMSO-d6): δ = 1.81 (s, 3 H, 7-H), 2.95 (t,
3J4,5 = 6.6 Hz, 2 H, 4-H), 3.27
(dt, 3J5,4 ≈
3J5,NH = 6.4 Hz, 2 H, 5-H), 3.43 (s, 2 H, 2-H), 6.76 (br. s, 1 H, N-H).
13C-NMR (125 MHz,
CDCl3, DMSO-d6): δ = 22.7, 28.7, 38.6, 49.3, 167.6, 170.3, 191.5.
2-(2,2-dimethyl-5-oxo-1,3-dioxolan-4-yl)acetic acid (12)11
A solution of racemic malic acid (3.00 g, 22.4 mmol, 1.0 equiv) and p-toluene
sulfonic acid monohydrate (85 mg, 0.45 mmol, 2 mol%) in a mixture of 25 mL of 2,2-
dimethoxypropane and 25 mL acetone was stirred at room temperature for 5 hours. Then sodium
bicarbonate (38 mg, 0.45 mmol, 2 mol%) and 50 mL of water were added. The mixture was extracted
with DCM (3 x 100 mL) and the combined organic layers were dried (Na2SO4). After filtration and
removal of the solvent in vacuo the crude product was recrystallized from PE/Et2O (97:3). The
protected malic acid 12 (1.74 g, 10.0 mmol, 45%) was isolated as a white solid.
m.p. 74–77°C 1
H-NMR (400 MHz, CDCl3): δ = 1.56 (s, 3 H, 6-H), 1.61 (s, 3 H, 6-H'), 2.85 (dd,
2J2a,2b = 17.2 Hz,
3J2a,3 = 6.6 Hz, 1 H, 2-Ha), 2.99 (dd,
2J2b,2a = 17.2 Hz,
3J2b,3 = 3.8 Hz, 1 H, 2-
Hb), 4.71 (dd, 3J3,2a = 6.6 Hz,
3J3,2b = 3.8 Hz, 1 H, 3-H), 10.23 (br. s, 1 H, COO-H). 13
C-NMR
(100 MHz, CDCl3): δ = 25.8, 26.7, 36.0, 70.4, 111.4, 171.8, 175.1.
S19
S-(2-acetamidoethyl) 2-(2,2-dimethyl-5-oxo-1,3-dioxolan-4-yl)ethanethioate (13)
To a mixture of the protected malic acid 12 (300 mg, 1.72 mmol, 1.05
equiv) and DIPEA (344 µL, 1.97 mmol, 1.2 equiv) in 17 mL of DCM was added ethyl chloroformate
(158 µL, 1.64 mmol, 1.0 equiv) dropwise at 0 °C. After 5 minutes, N-acetylcysteamine 1b (196 mg,
1.64 mmol, 1.0 equiv) was added and the mixture was allowed to warm to room temperature. After 3
hours the reaction mixture was diluted with DCM (30 mL) and washed once with 1 M HCl-solution
(10 mL) and sat. NaHCO3-solution (10 mL). The organic layer was dried (Na2SO4) and filtered. After
removal of the solvent in vacuo the thioester 13 (369 mg, 1.34 mmol, 82%) was isolated as a colorless
liquid.
1H-NMR (500 MHz, CDCl3): δ = 1.57 (s, 3 H, 10-H), 1.62 (s, 3 H, 10-H'), 2.00 (s, 3 H, 8-H),
3.06 (dd, 2J3a,3b = 16.5 Hz,
3J3a,2 = 6.7 Hz, 1 H, 3-Ha), 3.11 (td,
3J5,6 = 6.4 Hz,
4J5,NH = 2.1 Hz,
2 H, 5-H), 3.19 (dd, 2J3b,3a = 16.5 Hz,
3J3b,2 = 4.0 Hz, 1 H, 3-Hb), 3.46 (m, 2 H, 6-H), 4.76 (dd,
3J2,3a = 6.7 Hz,
3J2,3b = 4.3 Hz, 1 H, 2-H), 6.29 (br. s, 1 H, N-H). 13
C-NMR (100 MHz, CDCl3): δ
= 23.0, 25.8, 26.8, 28.8, 39.3, 44.8, 70.5, 111.4, 170.7, 171.8, 195.0. HRMS: [C11H17NO5S+K]*
calculated 314.0450 found: 314.0459, Rf(silica, EA) = 0.40.
4-((2-acetamidoethyl)thio)-2-hydroxy-4-oxobutanoic acid (9b)
A solution of the thioester 13 (87 mg, 0.317 mmol, 1.0 equiv) in a
mixture of 2.5 mL THF and 1 mL of 1 M HCl solution was heated to 50 °C. After one hour, TLC-
analysis showed complete conversion of the starting material. The reaction was cooled to room
temperature and extracted with EA (5 mL). The organic layer was again extracted with 2 mL of 1 M
HCl-solution and the combined aqueous layers were dried in vacuo giving access to the malyl
thioester 9b (51.4 mg, 0.218 mmol, 69%) as a colorless resin.
S20
1H-NMR (500 MHz, D2O): δ = 1.89 (s, 3 H, 8-H), 3.01 (m, 2 H, 5-H), 3.07 (dd,
2J3a,3b = 16. 2 Hz,
3J3a,2
= 6.7 Hz, 1 H, 3-Ha), 3.13 (dd, 2J3b,3a = 15.9 Hz,
3J3b,2 = 4.6 Hz, 1 H, 3-Hb), 3.32 (t,
3J6,5 = 6.3 Hz, 2 H,
6-H), 4.57 (dd, 3J2,3a = 6.9 Hz,
3J2,3b = 4.1 Hz, 1 H, 2-H).
13C-NMR (125 MHz, DMSO-d6): δ = 25.2,
30.8, 40.8, 50.6, 69.6, 172.0, 176.8, 198.4. HRMS: [C8H13NO5S+H]* calculated 236.0587 found:
236.0583.
2,5,8,15,18,21-hexaoxa-11,12-dithiadocosane (11)
A solution of the thiol 1c (300 mg,
1.66 mmol, 1.0 equiv) in 2 mL of EA was treated with sodium iodide (1 mg, 8 µmol, 0.5 mol%) and
aqueous hydrogen peroxide solution (33 wt.%, 160 µL, 1.83 mmol, 1.1 equiv) and stirred at room
temperature. After one hour the resulting brown solution was treated with Na2S2O3 solution (5 wt.%, 2
mL), followed by further stirring for 5 minutes. Then the layers were separated, and the aqueous layer
was extracted two more times with EA (2 x 5 mL). The combined organic layers were dried (Na2SO4)
and filtered. The solvent of the filtrate was removed in vacuo which gave access to 11 (287 mg, 0.80
mmol, 96%) as a pale yellow oil.
1H-NMR (400 MHz, CDCl3): δ = 2.88 (t,
3J7,6 = 6.7 Hz, 4 H, 7-H), 3.37 (s, 6 H, 1-H), 3.55 (m, 4 H, 2-
H), 3.62–3.72 (m, 12 H, 3-H, 4-H, 5-H), 3.72 (t, 3J6,7 = 6.7 Hz, 4 H, 6-H).
13C-NMR (125 MHz,
CDCl3): δ = 38.3, 59.0, 69.6, 70.3, 70.51, 71.52, 71.9. HRMS: [C14H30O6S2+Na]+ calculated:
381.1376 found: 381.1384.
S21
3.3. Formation of thioesters under prebiotic conditions
General procedures for thioester formation:
Method A (K2S2O8, FeS, 70 °C):
To a solution of the thiol (0.1 mmol) in 3 mL of MilliQ water in a Pyrex pressure tube with a stirring
bar was added the corresponding α-keto acid (0.50 mmol; 0.42 mmol for hydroxyketoglutarate) or
acetaldehyde (1.0 mmol) under a constant argon flow. Iron(II) sulfide (0.05 mmol) and potassium
persulfate (0.2 mmol) were added. The reaction vessel was closed and heated to 70 °C for 3 hours.
After cooling to room temperature, the amount of thioester formed was determined by GC-FID
analysis or LCMS analysis (see section 2.1 and 2.2). Additionally selected samples were analyzed by
NMR using water suppression (see section 2.4).
Method B (K2S2O8, FeS, UV-A):
To a solution of the thiol (0.1 mmol) in 3 mL of MilliQ water in a quartz tube with a stirring bar was
added the corresponding α-keto acid (0.50 mmol; 0.42 mmol for hydroxyketoglutarate) or
acetaldehyde (1.0 mmol) under a constant argon flow. Iron(II) sulfide (0.05 mmol) and potassium
persulfate (0.2 mmol) were added. The tube was closed with a septum and irradiated in a Luzchem
LZC-ORG photoreactor equipped with 10 LZC-UVA lamps for 6 hours. The amount of thioester
formed was determined by GC-FID analysis or LCMS analysis (see section 2.1 and 2.2). Additionally
selected samples were analyzed by NMR using water suppression (see section 2.4).
Method C (KHSO4, UV-A):
To a solution of the thiol (0.1 mmol) in 3 mL of a KHSO4-solution (3 M in MilliQ water) in a quartz
tube with a stirring bar was added the corresponding α-keto acid (0.50 mmol; 0.42 mmol for
hydroxyketoglutarate) or acetaldehyde (1.0 mmol) under a constant argon flow. The tube was closed
with a septum and irradiated in a Luzchem LZC-ORG photoreactor equipped with 10 LZC-UVA
lamps for 6 hours. The amount of thioester formed was determined by GC-FID analysis or LCMS
analysis (see section 2.1 and 2.2). Additionally selected samples were analyzed by NMR using water
suppression (see section 2.4).
S22
Hydroxyketoglutarate was synthesized by adapting a literature procedure without isolation of the
product.3 To a solution of glyoxylic acid hydrate (506 mg, 5.50 mmol, 1.1 equiv) in 30 mL of MilliQ
water was added oxaloacetic acid (660 mg, 5.00 mmol, 1.0 equiv) and NaHCO3 (840 mg, 10.0 mmol,
2.0 equiv) under argon. The resulting mixture was stirred at room temperature for two hours. A
concentration of 139 mM for the resulting hydroxyketoglutarate was determined by NMR analysis
with water suppression using DSS as an internal standard.
S23
Table S-1: Optimization of the oxidative decarboxylation of sodium pyruvate with 1b.
Entry Additive (equiv/conc) Light source/T t [h] Yield(3b) [%]
1 none UVA/-B/-C/CW 3 0.6 ± 0.2
2 none 70 °C 3 0.0 ± 0.0
3 K2S2O8 (2 equiv) rt 3 1.5 ± 0.7
4 K2S2O8 (2 equiv) 50 °C 3 9.0 ± 0.9
5 K2S2O8 (2 equiv) 70 °C 3 14.8 ± 0.7
6 K2S2O8 (2 equiv) 100 °C 3 8.6 ± 0.8
7 K2S2O8 (2 equiv) UVA/-B/-C/CW 3 6.4 ± 1.8
8 K2S2O8 (2 equiv) + FeS (0.5 equiv) UVA/-B/-C/CW 3 23.1 ± 2.7
9 K2S2O8 (2 equiv) + FeS (0.5 equiv) 70 °C 3 21.2 ± 0.5
10 KHSO4 (3 M) UVA 6 22.1 ± 0.4
11 Fe(ClO4)3 (1.0 equiv) UVA 6 4.8 ± 0.4
12 K2S2O8 (2 equiv) + FeS (0.5 equiv) UVA 6 31.2 ± 0.4
13 K2S2O8 (2 equiv) + FeS (0.5 equiv) 70 °C 3 26.6 ± 0.7
14 KHSO4 (1 M) UVA/-B/-C/CW 3 6.2 ± 0.2
15 KHSO4 (3 M) UVA/-B/-C/CW 3 8.4 ± 1.9
16 NaHSO4 (1 M) UVA/-B/-C/CW 3 4.4 ± 0.9
17 H2SO4 (1 M) UVA/-B/-C/CW 3 6.8 ± 0.3
18 H3PO4 (3 M) UVA/-B/-C/CW 3 6.1 ± 0.3
19 HCl (0.5 M) UVA/-B/-C/CW 3 2.5 ± 0.2
20 H2SO4 (1 M) or H3PO4 (3 M) or HCl
(0.5 M) or KHSO4 (3 M) 70 °C 3 0 ± 0
21 nonea UVA/-B/-C/CW 3 1.8 ± 0.0
22 KHSO4 (1 M) none 3 0.5 ± 0.1
23 KHSO4 (1 M) UVA 3 14.2 ± 0.7
24 KHSO4 (1 M) UVB 3 9.5 ± 1.0
25 KHSO4 (1 M) UVC 3 0.8 ± 0.0
26 KHSO4 (1 M) CW 3 0.6 ± 0.1
27 KHSO4 (3 M) b UVA 6 4.9 ± 0.2
28 Fe(ClO4)3 (1.0 equiv) b
UVA 6 0.5 ± 0.1
29 K2S2O8 (2 equiv) + FeS (0.5 equiv) b UVA 6 31.9 ± 0.7
S24
Entry Additive (equiv/conc) Light source/T t [h] Yield(3b) [%]
30 K2S2O8 (2 equiv) + FeS (0.5 equiv) b 70 °C 3 32.9 ± 0.8
31 KHSO4 (0.5 M) UVA 3 7.2 ± 0.5
32 KHSO4 (0.41 M) + K2SO4 (0.09 M) UVA 3 6.6 ± 0.3
33 KHSO4 (0.33 M) + K2SO4 (0.17 M) UVA 3 5.5 ± 0.3
34 KHSO4 (0.25 M) + K2SO4 (0.25 M) UVA 3 4.4 ± 0.7
35 KHSO4 (0.17 M) + K2SO4 (0.33 M) UVA 3 3.0 ± 0.1
36 KHSO4 (0.09 M) + K2SO4 (0.41 M) UVA 3 1.4 ± 0.1
37 KHSO4 (0.46 M) + K2SO4 (0.04 M) UVA 3 0.8 ± 0.1
38 K2SO4 (0.5 M) UVA 3 0.5 ± 0.0
39 Fe(ClO4)3 (2 equiv) UVA/-B/-C/CW 3 4.4 ± 0.3
40 FeCl2 (2 equiv) UVA/-B/-C/CW 3 2.8 ± 0.1
41 FeCl3 (2 equiv) UVA/-B/-C/CW 3 3.1 ± 0.1
42 FeS (2 equiv) UVA/-B/-C/CW 3 1.1 ± 0.2
43 KHSO4 (3 M)c UVA 6 0.0 ± 0.0
44 K2S2O8 (2 equiv) + FeS (0.5 equiv)c UVA 6 0.0 ± 0.0
45 K2S2O8 (2 equiv) + FeS (0.5 equiv)c 70 °C 3 0.0 ± 0.0
46 KHSO4 (3 M)d UVA 6 0.0 ± 0.0
47 K2S2O8 (2 equiv) + FeS (0.5 equiv)d UVA 6 0.0 ± 0.0
48 K2S2O8 (2 equiv) + FeS (0.5 equiv)d 70 °C 3 0.0 ± 0.0
a pyruvic acid was used instead of sodium pyruvate
b 0.5 equiv disulfide 1d instead of thiol 1b.
ccontrol experiment without sodium pyruvate
dcontrol experiment without thiol 1b
To show that the described method can also be applied to other thiols, the formation of the acetyl
thioester 3c starting from pyruvate and the thiol 1c has been investigated.
Scheme S-3: Thioester formation with an alternative thiol 1c analyzed by GC-FID.
S25
Additionally, the use of α-hydroxy acids instead of α-keto acids has been investigated.
Scheme S-4: Thioester formation using lactic acid analyzed by GC-FID.
Figure S-9: Time dependence of the thioester formation under optimized conditions
0
10
20
30
40
50
60
0 10 20 30 40 50
yie
ld 3
b[%
]
time [h]
K2S2O8 + FeS, 70°C
K2S2O8 + FeS, UVA
KHSO4, UVA
S26
Table S-2: Stability and decomposition products of different keto acids using methods A–C
Me
O
O-
OMe S
O
R
pyruvate (2)
O
O-
O
oxaloacetate 6 (n = 1)
α-ketoglutarate 4 (n = 2)
HO
O
n S
O
HO
O
n
R
malonyl thioester 8b (n = 1)
succinyl thioester 5b (n = 2)
acetyl thioester (3b/3c)RSH (1b/1c)
or RSSR (1d)
H2O
Ketoacid Thio-cmpd. Method Remaining Ketoacida
Decompositiona
pyruvate 1b A 48%b acetate (7%)
pyruvate 1b B 48%b acetate (10%)
pyruvate 1b C 64%b acetate (2%)
pyruvate 1c A 63%b acetate (4%)
pyruvate 1c B 48%b acetate (9%)
pyruvate 1c C 63%b acetate (4%)
pyruvate 1d A 54%b acetate (4%)
pyruvate 1d B 56%b acetate (13%)
pyruvate 1d C 80%b acetate (1%)
α-ketoglutarate 1b A 66%b succinate (5%)
α-ketoglutarate 1b B 82% b succinate (7%)
α-ketoglutarate 1b C 57% b succinate (1%)
oxaloacetate 1b A 0% pyruvate (52%b)
oxaloacetate 1b B 0% pyruvate (32%b)
oxaloacetate 1b C 44%b pyruvate (4%
b)
a determined by NMR with DSS as internal standard using water suppression
b the shown value is the
sum of the ketoacid and its hydrate form
S27
3.4 Thioester formation from a non-enzymatic reaction network
A solution of sodium pyruvate 2 (110 mg, 1.0 mmol, 2.0 equiv), glyoxylic acid monohydrate (46 mg,
0.5 mmol, 1.0 equiv) and FeCl2∙4H2O (200 mg, 1.0 mmol, 2.0 equiv) in 3 mL of MilliQ water was
prepared in a Pyrex pressure tube equipped with a stirring bar under a constant argon flow. For
oxidation procedure A N-acetylcysteamine 1b (59 mg, 0.5 mmol, 1.0 equiv) was added. The reaction
vessel was closed and heated to 70 °C for 1 h or 3 h, followed by an oxidation procedure.
Oxidation procedure A:
To the solution prepared as described above, potassium persulfate (270 mg, 1.0 mmol, 1.0 equiv) was
added under a constant argon flow. The reaction vessel was closed and heated to 70 °C for 3 hours.
After cooling to room temperature, the amount of thioesters formed was determined by GC-FID
analysis or LCMS analysis (see section 2.1 and 2.2), the different intermediates of the network were
determined by GC-MS analysis (see section 2.3).
Oxidation procedure B: (in this case, N-acetylcysteamine was added at a later stage)
To the solution prepared as described above, KHSO4 (1.2 g, 9.0 mmol, to form a ~3 M solution) and
N-acetylcysteamine (59 mg, 0.50 mmol 1.0 equiv) were added, the mixture was transferred in a quartz
tube under a constant argon flow. The tube was closed with a septum and irradiated in a Luzchem
LZC-ORG photoreactor equipped with 10 LZC-UVA lamps for 3 hours. The amount of thioesters
formed was determined by GC-FID analysis or LCMS analysis (see section 2.1 and 2.2), the different
intermediates of the network were determined by GC-MS analysis (see section 2.3).
S28
Table S-3: Thioester formation from a non-enzymatic reaction network
Me
O
O
O
H
O
O
O
pyruvate
glyoxylate
FeCl2 (2 equiv)addition 1
conditions 1H2O
-O
O
O
-O
O
O
O-
O
α2εetoglutarate
hydroxyketoglutarate
Me
O
O
Opyruvate
Reaction networkwith 16 biological
intermediates
SR
O
-O
O
Me SR
O
CO2
O-
O
SR
O
-O
O
acetyl thioester (3b)
malyl thioester (9b)
succinyl thioester (5b)
OH
OH
addition 2conditions 2
Entry equiv pyruvate addition 1 (equiv) conditions 1 addition 2 (equiv) conditions 2 c(3b)a [mM] c(5b)
b [mM] c(9b)
b [mM]
1 2 70 °C, 1 h Thiol (1)
KHSO4 (3 M) UVA, 3 h 0.11 ± 0.01 0.19 ± 0.04 0.06 ± 0.00
2 2 Thiol (1) 70 °C, 1 h K2S2O8 (2) 70 °C, 3 h 1.41 ± 0.11 0.11 ± 0.01 3.60 ± 0.30
3 2 Thiol (1) 70 °C, 3 h K2S2O8 (2) 70 °C, 3 h 1.11 ± 0.14 0.11 ± 0.02 3.63 ± 0.28
4 1 Thiol (1)
KHSO4 (3 M) UVA, 3 h - - 0.06 ± 0.05 - -
5 2 Thiol (1)
KHSO4 (3 M) UVA, 6 h - - 0.16 ± 0.02 - -
6 1 Thiol (1)
KHSO4 (3 M) UVA, 3 h - - 0.11 ± 0.05 - -
7 2 Thiol (1)
KHSO4 (3 M) UVA, 6 h - - 0.31 ± 0.05 - -
8 2 Thiol (1) 70 °C, 1 h KHSO4 (3M) UVA, 3 h 0.12 ± 0.01 - -
9 2 Thiol (1) 70 °C, 1 h KHSO4 (3M) UVA, 6 h 0.15 ± 0.01 - -
10 2 Thiol (1) UVA, 1 h KHSO4 (3M) UVA, 3 h 0.22 ± 0.02
a Determined by GC-FID analysis after extraction with ethyl acetate
b Determined by LCMS-analysis. For the network experiments 0.5 µL instead of 0.1 µL were
injected, the resulting value calculated using the calibration curves was divided by 5 afterwards. See section 4.10 for GCMS-chromatograms of the network
products.
S29
4. Experimental data
4.1. NMR spectra of the synthesized compounds
N,N'-(disulfanediylbis(ethane-2,1-diyl))diacetamide (1d)
10 9 8 7 6 5 4 3 2 1 0Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
No
rma
lize
d In
ten
sity
6.1
2
4.0
0
4.0
9
1.7
76
.68
3.5
83
.56
3.5
53
.54
2.8
42
.83
2.8
1
2.0
3
200 180 160 140 120 100 80 60 40 20 0Chemical Shift (ppm)
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
No
rma
lize
d In
ten
sity
17
0.9
3
38
.58
37
.69
23
.11
S30
2-(2-(2-methoxyethoxy)ethoxy)ethyl 4-methylbenzenesulfonate (10)
8 7 6 5 4 3 2 1 0Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
No
rma
lize
d In
ten
sity
3.0
7
3.1
2
2.0
9
6.2
4
2.5
8
2.0
2
2.0
0
2.0
07
.80
7.7
8
7.3
47
.32
4.1
64
.15
4.1
43
.69
3.6
83
.67
3.3
6
2.4
4
S31
S-(2-(2-(2-methoxyethoxy)ethoxy)ethyl) ethanethioate (3c)
8 7 6 5 4 3 2 1 0Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
No
rma
lize
d In
ten
sity
3.0
0
2.0
3
2.9
2
2.0
0
8.0
5
3.3
73
.09
3.0
83
.06
2.3
2
200 180 160 140 120 100 80 60 40 20 0Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
No
rma
lize
d In
ten
sity
19
5.4
6
71
.90
70
.54
70
.51
70
.28
69
.72
59
.00
30
.50
28
.80
S32
2-(2-(2-methoxyethoxy)ethoxy)ethane-1-thiol (1c)
8 7 6 5 4 3 2 1 0Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
No
rma
lize
d In
ten
sity
0.8
8
1.9
6
3.0
0
2.0
6
8.2
2
3.3
7
2.7
12
.69
2.6
72
.66
1.5
91
.57
1.5
5
200 180 160 140 120 100 80 60 40 20 0Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
No
rma
lize
d In
ten
sity
72
.88
71
.93
70
.56
70
.22
59
.03
24
.25
S33
N,S-diacetyl cysteamine (3b)
8 7 6 5 4 3 2 1 0Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
No
rma
lize
d In
ten
sity
2.8
9
2.9
9
2.0
2
2.0
0
0.8
35
.96
3.4
43
.43
3.4
13
.39
3.0
33
.01
3.0
0
2.3
4
1.9
6
240 220 200 180 160 140 120 100 80 60 40 20 0 -20Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
No
rma
lize
d In
ten
sity
19
6.3
3
17
0.3
6
39
.52
30
.57
28
.71
23
.12
S34
2,5,8,15,18,21-hexaoxa-11,12-dithiadocosane (11)
8 7 6 5 4 3 2 1 0Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
No
rma
lize
d In
ten
sity
4.0
0
5.9
44
.08
12
.30
4.0
1
3.7
43
.72
3.7
13
.65
3.6
43
.64
3.6
33
.56
3.5
43
.37
2.9
02
.88
2.8
6
180 160 140 120 100 80 60 40 20 0Chemical Shift (ppm)
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
Norm
aliz
ed I
nte
nsity
71.8
770.5
270.3
269.5
7
59.0
0
38.3
2
70.5 70.4 70.3 70.2Chemical Shift (ppm)
0.25
0.50
0.75
1.00
Norm
aliz
ed I
nte
nsity
70.5
270.5
1
70.3
2
S35
4-[[2-(Acetylamino)ethyl]thio]-4-oxobutanoic acid (5b)
9 8 7 6 5 4 3 2 1 0 -1Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
Norm
aliz
ed I
nte
nsity
3.0
0
2.0
4
2.1
4
2.0
8
2.1
5
1.2
35.9
9
3.4
53.4
43.4
33.0
73.0
63.0
52.9
22.9
02.8
92.7
42.7
3
1.9
7
220 200 180 160 140 120 100 80 60 40 20 0Chemical Shift (ppm)
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0.08
0.09
0.10
0.11
0.12
0.13
Norm
aliz
ed I
nte
nsity
198.4
5
175.4
6170.9
9
39.6
538.2
4
28.8
928.4
6
23.0
4
S36
3-((2-acetamidoethyl)thio)-3-oxopropanoic acid (8b)
12 11 10 9 8 7 6 5 4 3 2 1 0 -1Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
Norm
aliz
ed I
nte
nsity
3.0
3
2.0
0
2.1
4
1.9
6
1.0
36.7
6
3.4
33.2
93.2
83.2
63.2
52.9
62.9
52.9
3
1.8
1
220 200 180 160 140 120 100 80 60 40 20 0Chemical Shift (ppm)
0.05
0.10
0.15
0.20
0.25
0.30
Norm
aliz
ed I
nte
nsity
DMSO-d6
CDCl3
191.5
2
170.3
1167.6
1
49.2
7
38.6
1
28.7
0
22.6
7
S37
2-(2,2-dimethyl-5-oxo-1,3-dioxolan-4-yl)acetic acid (12)
12 11 10 9 8 7 6 5 4 3 2 1 0Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
Norm
aliz
ed I
nte
nsity
3.0
5
2.9
7
1.0
2
1.0
0
0.9
5
0.9
610.2
3
4.7
24.7
14.7
04.7
0
3.0
13.0
12.9
82.9
72.8
82.8
62.8
4
1.6
11.5
6
200 180 160 140 120 100 80 60 40 20 0Chemical Shift (ppm)
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
Norm
aliz
ed I
nte
nsity
175.1
3171.8
4
111.3
7
70.3
5
35.9
6
26.7
025.7
9
S38
S-(2-acetamidoethyl) 2-(2,2-dimethyl-5-oxo-1,3-dioxolan-4-yl)ethanethioate (13)
10 9 8 7 6 5 4 3 2 1 0 -1Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
Norm
aliz
ed I
nte
nsity
3.4
9
3.3
4
3.0
0
1.2
1
1.9
4
1.0
2
2.1
8
1.1
0
1.0
26.2
9
4.7
74.7
64.7
64.7
5
3.4
73.4
63.4
53.1
73.1
13.1
13.0
93.0
83.0
7
2.0
01.6
21.5
7
220 200 180 160 140 120 100 80 60 40 20 0 -20Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
Norm
aliz
ed I
nte
nsity
195.0
0
171.8
0170.6
7
111.3
9
70.4
7
44.8
1
39.2
8
28.7
726.7
925.8
023.0
0
S39
4-((2-acetamidoethyl)thio)-2-hydroxy-4-oxobutanoic acid (9b)
9 8 7 6 5 4 3 2 1 0Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
Norm
aliz
ed I
nte
nsity
3.0
0
2.2
6
2.0
4
2.0
6
1.0
44.5
84.5
74.5
74.5
6
3.3
33.3
23.3
03.1
23.1
13.0
93.0
83.0
23.0
2
1.8
9
220 200 180 160 140 120 100 80 60 40 20 0Chemical Shift (ppm)
0.05
0.10
0.15
0.20
No
rma
lize
d In
ten
sity
19
8.4
4
17
6.7
9
17
1.9
9
69
.55
50
.64
40
.83
30
.80
25
.19
S40
4.2. NMR spectra of reference compds. in H2O/D2O with DSS as IS with water suppression
N-acetyl cysteamine (1b) in H2O/D2O+DSS
8 7 6 5 4 3 2 1 0 -1Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
No
rma
lize
d In
ten
sity
3.0
0
1.8
0
1.5
5
0.4
7DSS DSSDSS DSS
3.3
93
.37
3.3
53
.33
2.9
32
.91
2.8
82
.85
2.6
82
.66
2.6
42
.00
1.8
11
.78
1.7
61
.73
0.6
50
.62
0.6
0
0.0
0
2-(2-(2-methoxyethoxy)ethoxy)ethane-1-thiol (1c) in H2O/D2O+DSS
8 7 6 5 4 3 2 1 0 -1Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
No
rma
lize
d In
ten
sity
0.6
3
2.4
6
3.0
0
7.9
6
DSS DSS DSS DSS
3.6
9
3.3
72
.93
2.9
12
.88
2.7
3
1.7
5
0.6
50
.62
0.6
0
0.0
0
S41
N,N'-(disulfanediylbis(ethane-2,1-diyl))diacetamide (1d) in H2O/D2O+DSS
9 8 7 6 5 4 3 2 1 0 -1Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
No
rma
lize
d In
ten
sity
6.0
0
4.1
3
2.9
2
DSS DSSDSS DSS
8.1
2
3.5
33
.51
3.4
93
.47
2.8
72
.85
2.8
31
.99
1.8
11
.78
1.7
71
.76
1.7
41
.73
1.7
00
.65
0.6
20
.60
0.0
0
N,S-diacetyl cysteamine (3b) in H2O/D2O+DSS
8 7 6 5 4 3 2 1 0 -1Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
No
rma
lize
d In
ten
sity
2.9
4
3.0
0
2.2
3
1.8
4
0.4
3
DSS DSSDSS DSS
8.1
0
3.4
03
.38
3.3
63
.34
3.0
53
.03
3.0
12
.93
2.9
12
.88
2.3
71
.95
1.7
81
.75
1.7
41
.73
0.6
50
.62
0.6
0
0.0
0
S42
S-(2-(2-(2-methoxyethoxy)ethoxy)ethyl) ethanethioate (3c) in H2O/D2O+DSS
8 7 6 5 4 3 2 1 0 -1Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
No
rma
lize
d In
ten
sity
3.0
0
2.0
3
2.3
2
6.3
5
DSSDSS DSSDSS
3.3
73
.14
3.1
23
.10
2.9
32
.90
2.8
82
.85
2.3
81
.81
1.7
91
.77
1.7
51
.74
1.7
21
.72
0.6
50
.62
0.6
0
0.0
0
4-[[2-(Acetylamino)ethyl]thio]-4-oxobutanoic acid (5b) in H2O/D2O+DSS
9 8 7 6 5 4 3 2 1 0 -1Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
No
rma
lize
d In
ten
sity
3.0
0
2.6
3
5.5
6
2.0
4
2.0
1
DSS
5b+DSS
DSS
DSS
3.4
03
.38
3.3
63
.34
3.0
83
.06
3.0
42
.72
2.6
92
.67
1.9
5
S43
2,5,8,15,18,21-hexaoxa-11,12-dithiadocosane (11) in H2O/D2O+DSS
8 7 6 5 4 3 2 1 0 -1Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
No
rma
lize
d In
ten
sity
5.1
7
5.9
9
3.1
5
9.7
4
2.3
3DSSDSS
DSS
3.8
43
.82
3.8
0
3.3
7
2.9
72
.95
2.9
3
3-((2-acetamidoethyl)thio)-3-oxopropanoic acid (8b) in H2O/D2O+DSS
6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0Chemical Shift (ppm)
0
0.25
0.50
0.75
1.00
No
rma
lize
d In
ten
sity
3.0
0
2.0
5
1.8
3
DSS
DSS
DSSDSS
3.4
33
.41
3.3
93
.37
3.1
23
.10
3.0
8
1.9
5
O
23
O
76S
4
5
NH
1HO
O
S44
sodium pyruvate (1)
10 9 8 7 6 5 4 3 2 1 0 -1Chemical Shift (ppm)
0
0.25
0.50
No
rma
lize
d In
ten
sity
0.0
8
0.7
4
pyruvate-hydratepyruvate
2.3
7
1.4
8
0.0
0
10 9 8 7 6 5 4 3 2 1 0 -1Chemical Shift (ppm)
0
0.25
0.50
No
rma
lize
d In
ten
sity
6.1
2
3.0
0
pyruvate-hydratepyruvate
2.4
7
1.5
9
0.0
010 9 8 7 6 5 4 3 2 1 0 -1
Chemical Shift (ppm)
0
0.25
0.50
No
rma
lize
d In
ten
sity
5.6
0
3.0
0
pyruvate pyruvate-hydrate
2.4
9
1.6
0
0.0
0
in H2O / D2O + DSS
in KHSO4 (1 M) / D2O + DSS
in KHSO4 (3 M) / D2O + DSS
S45
oxaloacetic acid (6)
10 9 8 7 6 5 4 3 2 1 0 -1Chemical Shift (ppm)
0
0.25
0.50
Norm
aliz
ed I
nte
nsity
2.0
03.0
2
0.0
0
10 9 8 7 6 5 4 3 2 1 0 -1Chemical Shift (ppm)
0
0.25
0.50
Norm
aliz
ed I
nte
nsity
2.0
03.0
4
0.0
0
10 9 8 7 6 5 4 3 2 1 0 -1Chemical Shift (ppm)
0
0.25
0.50
Norm
aliz
ed I
nte
nsity
2.0
03.0
7
0.0
0
in H2O / D2O + DSS
in KHSO4 (1 M) / D2O + DSS
in KHSO4 (3 M) / D2O + DSS
S46
α-ketoglutaric acid (4) in H2O/D2O+DSS
9 8 7 6 5 4 3 2 1 0 -1Chemical Shift (ppm)
0
0.25
0.50
0.75
1.00
No
rma
lize
d In
ten
sity
1.3
7
1.4
1
2.0
0
1.2
1
a-KG-hydrate
a-KG
a-KG-hydrate
a-KG
3.0
32
.75
2.7
22
.70
2.5
22
.49
2.4
72
.19
2.1
62
.14
succinic acid in H2O/D2O+DSS
12 11 10 9 8 7 6 5 4 3 2 1 0 -1 -2Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
No
rma
lize
d In
ten
sity
4.0
02
.66
0.0
0
S47
malonic acid in H2O/D2O+DSS
9 8 7 6 5 4 3 2 1 0 -1Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
No
rma
lize
d In
ten
sity
2.0
03
.50
0.0
0
S48
4.3. NMR spectra of selected reaction mixtures showing prebiotic thioester formations
Table 1, Entry 1, Method A
9 8 7 6 5 4 3 2 1 0 -1Chemical Shift (ppm)
0
0.25
0.50
0.75
1.00
No
rma
lize
d In
ten
sity
7.9
0
9.7
9
3.0
0
6.1
3
3.5
8
18
.65
3b
1d
pyruvate, 3b
acetic acid
DSS
2.3
92
.38
2.0
91
.99
1.9
61
.62
Table 1, Entry 1, Method B
9 8 7 6 5 4 3 2 1 0 -1Chemical Shift (ppm)
0
0.25
0.50
0.75
1.00
No
rma
lize
d In
ten
sity
7.8
3
9.5
1
3.0
0
5.0
5
5.3
42
.97
15
.52
pyruvate
3b 1d
3b
pyruvate-hydrate
acetic acid
DSS
2.3
92
.37
2.0
91
.99
1.9
61
.60
S49
Table 1, Entry 1, Method C
9 8 7 6 5 4 3 2 1 0 -1Chemical Shift (ppm)
0
0.25
0.50
0.75
1.00
No
rma
lize
d In
ten
sity
18
.31
51
.96
3.1
4
19
.95
2.7
9
2.9
7
26
.10
acetic acid
3b 3b pyruvate-hydrate
1d
pyruvate
DSS
2.4
92
.39
2.1
12
.06
2.0
21
.60
0.0
0
Table 1, Entry 2, Method A
9 8 7 6 5 4 3 2 1 0 -1Chemical Shift (ppm)
0
0.25
0.50
0.75
1.00
No
rma
lize
d In
ten
sity
7.8
8
8.6
7
3.0
0
6.7
4
2.3
8
19
.81
3b
1d pyruvate-hydrate
pyruvate, 3b
acetic acid
DSS
2.0
92
.00
1.9
61
.63
S50
Table 1, Entry 2, Method B
9 8 7 6 5 4 3 2 1 0 -1Chemical Shift (ppm)
0
0.25
0.50
0.75
1.00
No
rma
lize
d In
ten
sity
6.5
3
9.3
8
3.0
0
6.4
5
5.6
8
2.9
6
15
.14
3b 3b
1d
pyruvate-hydrate
acetic acid
DSS
2.3
92
.37
2.0
91
.99
1.9
61
.58
0.0
0
Table 1, Entry 2, Method C
9 8 7 6 5 4 3 2 1 0 -1Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
No
rma
lize
d In
ten
sity
11
2.5
8
39
4.6
1
3.1
6
16
0.0
9
7.8
9
3.0
0
20
4.1
6
3b 3b
acetic acid
pyruvate-hydrate
1d
pyruvate
DSS
2.4
9
2.1
12
.06
2.0
2
1.6
0
0.0
0
S51
Table 1, Entry 3, Method A
6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5 -1.0Chemical Shift (ppm)
0
0.25
0.50
0.75
1.00
Norm
aliz
ed I
nte
nsity
18.6
7
2.9
9
15.9
0
14.3
7
15.2
6
7.8
8
41.0
5
31.0
62.3
4
3.8
44.0
5
succinic acid 5b
1b, 1d
5b
a-KG
1d
a-KG-hydrate
a-KG-hydrate
1b, 5d
a-KG
DSS
3.5
13.4
93.3
83.3
63.0
83.0
63.0
42.9
92.7
42.7
12.6
92.6
72.5
32.5
12.4
82.2
42.2
22.1
91.9
91.9
5
Table 1, Entry 3, Method B
9 8 7 6 5 4 3 2 1 0 -1Chemical Shift (ppm)
0
0.25
0.50
0.75
1.00
No
rma
lize
d In
ten
sity
8.0
9
3.0
0
6.8
7
5.5
8
6.2
0
4.7
1
26
.03
17
.19
2.6
4
2.7
2
1.0
7
succinic acid
5b
1b, 1d
5b
a-KG
a-KG-hydrate
a-KG
1d
1b, 5b
DSS
3.3
83
.36
3.0
63
.04
2.7
22
.70
2.6
72
.67
2.4
82
.46
2.1
92
.16
1.9
91
.99
1.9
5
0.0
0
S52
Table 1, Entry 3, Method C
8 7 6 5 4 3 2 1 0 -1Chemical Shift (ppm)
0
0.25
0.50
0.75
1.00
No
rma
lize
d In
ten
sity
27
.67
3.0
0
22
.73
31
.06
35
.87
1.7
2
39
.45
20
.65
10
.59
7.6
9
succinic acid
5b
1b, 1d
a-KG
a-KG-hydrate
1d DSS
1b, 5b
5b, a-KG
3.5
43
.51
2.7
82
.75
2.7
32
.68
2.5
32
.51
2.4
82
.20
2.1
82
.15
2.0
31
.98
0.0
0
Table 1, Entry 4, Method A
8 7 6 5 4 3 2 1 0 -1Chemical Shift (ppm)
0
0.25
0.50
0.75
1.00
No
rma
lize
d In
ten
sity
13
.53
26
.30
3.0
0
8.7
5
0.6
4
20
.80
2.8
9
3.6
2
pyruvate
1d3b
pyruvate-hydrate
8b
1d
1d, malonic acid
DSS
3.5
1
2.8
72
.85
2.8
3
2.4
22
.38
1.9
91
.96
1.5
9
0.0
0
S53
Table 1, Entry 4, Method B
5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0 -0.5 -1.0Chemical Shift (ppm)
0
0.25
0.50
0.75
1.00
No
rma
lize
d In
ten
sity
10
.58
10
.12
2.9
9
6.4
1
0.4
8
12
.71
2.3
3
2.2
8
3b
pyruvate
pyruvate-hydrate8b
1d
1d
1d, malonic acid
DSS
3.4
8
2.8
72
.85
2.8
3
2.4
02
.37
1.9
91
.95
1.6
1
0.0
0
Table 1, Entry 4, Method C
9 8 7 6 5 4 3 2 1 0 -1Chemical Shift (ppm)
0
0.25
0.50
0.75
1.00
No
rma
lize
d In
ten
sity
9.0
0
2.3
0
5.9
61
7.8
5
2.6
1
pyruvate-hydrate
oxaloacetate
1d
DSS
1d, malonic acid
1d, 8b
3.0
7
S54
Table 1, Entry 6, Method A
10 9 8 7 6 5 4 3 2 1 0 -1Chemical Shift (ppm)
0
0.25
0.50
0.75
1.00
No
rma
lize
d In
ten
sity
23
.10
44
.54
3.8
0
39
.05
3.0
1
6.2
8
2.8
9
13
.02
1d
3b
3b
acetaldehyde
DSS
3b acetaldehyde-hydrateacetaldehyde
9.6
99
.68
9.6
79
.66
8.1
3
3.4
03
.38
3.3
63
.34
2.8
72
.85
2.8
32
.38
2.2
42
.23
1.9
91
.96
1.3
31
.31
Table 1, Entry 6, Method B
10 9 8 7 6 5 4 3 2 1 0 -1Chemical Shift (ppm)
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
No
rma
lize
d In
ten
sity
17
.99
3.0
0
3b
DSS2.3
9
S55
Table 1, Entry 6, Method C
10 9 8 7 6 5 4 3 2 1 0 -1Chemical Shift (ppm)
0
0.25
0.50
0.75
1.00
No
rma
lize
d In
ten
sity
21
.46
62
.95
3.1
5
14
.75
55
.54
3.0
1
17
.63
3b
1d
3b
acetaldehyde
acetaldehyde-hydrateacetaldehyde
9.6
79
.66
2.3
72
.24
2.2
32
.08
1.9
91
.96
1.3
31
.31
Scheme S-3 Method A
9 8 7 6 5 4 3 2 1 0 -1Chemical Shift (ppm)
0
0.25
0.50
0.75
1.00
No
rma
lize
d In
ten
sity
8.9
9
14
.56
2.4
6
23
.28
11
.55
acetic acid
pyruvate-hydrate
pyruvate, 3c
DSS
1c, 3c, disulfide-1c
3.3
8
2.3
9
2.0
9
1.6
1
0.0
0
S56
Scheme S-3 Method B
9 8 7 6 5 4 3 2 1 0 -1Chemical Shift (ppm)
0
0.25
0.50
0.75
1.00
No
rma
lize
d In
ten
sity
9.8
4
14
.78
6.0
9
3.0
0
16
.79
10
.20
3c
pyruvate
1c, 3c, disulfide-1c
acetic acid
pyruvate-hydrate DSS
3.3
8
2.3
9
2.0
8
1.5
8
0.0
0
Scheme S-3 Method C
8 7 6 5 4 3 2 1 0 -1Chemical Shift (ppm)
0
0.25
0.50
0.75
1.00
No
rma
lize
d In
ten
sity
18
.42
50
.89
3.5
0
3.0
1
26
.38
39
.00
acetic acid
pyruvate-hydrate
3c
pyruvate
1c, 3c, disulfide-1c
DSS
2.1
1
S57
4.4. GC-FID chromatograms of authentic samples
N-acetylcysteamine (1b)
2-(2-(2-methoxyethoxy)ethoxy)ethane-1-thiol (1c)
S58
N,N'-(disulfanediylbis(ethane-2,1-diyl))diacetamide (1d)
N,S-diacetyl cysteamine (3b)
S59
S-(2-(2-(2-methoxyethoxy)ethoxy)ethyl) ethanethioate (3c)
2,5,8,15,18,21-hexaoxa-11,12-dithiadocosane (11)
S60
4.5. GC-FID chromatograms of the prebiotic thioester formation
Table 1, Entry 1, Method A
Table 1, Entry 1, Method B
sample retention time 3b (min) peak area (pA*s)
1 4.428 107.07
2 4.427 101.81
3 4.428 104.05
sample retention time 3b (min) peak area (pA*s)
1 4.429 124.39
2 4.429 121.55
3 4.429 121.66
S61
Table 1, Entry 1, Method C
Table 1, Entry 2, Method A
sample retention time 3b (min) peak area (pA*s)
1 4.430 131.20
2 4.430 130.21
3 4.430 136.76
sample retention time 3b (min) peak area (pA*s)
1 4.426 85.26
2 4.427 88.39
3 4.426 86.27
S62
Table 1, Entry 2, Method B
Table 1, Entry 2, Method C
sample retention time 3b (min) peak area (pA*s)
1 4.430 126.43
2 4.430 126.80
3 4.430 122.10
sample retention time 3b (min) peak area (pA*s)
1 4.415 18.18
2 4.418 19.78
3 4.418 19.58
S63
Table 1, Entry 6, Method A
Table 1, Entry 6, Method B
sample retention time 3b (min) peak area (pA*s)
1 4.423 60.35
2 4.423 61.44
3 4.422 51.50
sample retention time 3b (min) peak area (pA*s)
1 4.422 55.50
2 4.422 55.08
3 4.421 41.14
S64
Table 1, Entry 6, Method C
sample retention time 3b (min) peak area (pA*s)
1 4.418 67.62
2 4.423 76.15
3 4.423 70.98
S65
Scheme S-4, Method A
Scheme S-4, Method B
sample retention time 3b (min) peak area (pA*s)
1 4.417 13.46
2 4.418 12.99
3 4.418 14.66
sample retention time 3b (min) peak area (pA*s)
1 4.413 13.92
2 4.416 14.37
3 4.417 13.51
S66
Scheme S-4, Method C
Scheme S-3, Method A
sample retention time 3b (min) peak area (pA*s)
1 4.450 0
2 4.450 0
3 4.418 1.21
sample retention time 3c (min) peak area (pA*s)
1 5.089 153.22
2 5.090 152.67
3 5.088 147.95
S67
Scheme S-3, Method B
Scheme S-3, Method C
sample retention time 3c (min) peak area (pA*s)
1 5.092 260.85
2 5.092 254.51
3 5.091 248.65
sample retention time 3c (min) peak area (pA*s)
1 5.089 188.67
2 5.090 173.98
3 5.090 194.93
S68
4.6. GC-FID chromatograms of the network combined with thioester formation
Table S-3, Entry 1
Table S-3, Entry 2
sample retention time 3b (min) peak area (pA*s)
1 4.419 0.11
2 4.419 0.11
3 4.428 0.10
sample retention time 3b (min) peak area (pA*s)
1 4.418 1.28
2 4.418 1.48
3 4.418 1.46
S69
Table S-3, Entry 3
sample retention time 3b (min) peak area (pA*s)
1 4.418 1.21
2 4.418 0.75
3 4.418 1.01
S70
4.7. LC-MS chromatograms of authentic samples
N-acetyl cysteamine (1b) m/z = 119.95–120.15
RT: 0.00 - 10.02
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0
Time (min)
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lative
Ab
un
da
nce
RT: 0.57MA: 1942086443
0.847.66 8.388.20 8.610.95 7.577.096.826.642.67 8.631.27 6.262.891.93 9.112.17 5.733.24 9.973.54 4.523.84 9.674.12 4.76 5.445.250.42
NL:3.71E8
m/z= 119.95-120.15 MS ECB500-c5b
ECB500-c5b #61 RT: 0.57 AV: 1 SB: 240 0.00-0.51 , 0.98-2.73 NL: 3.41E8T: FTMS + p ESI Full ms [70.0000-700.0000]
100 150 200 250 300 350 400 450 500 550 600 650 700
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Rela
tive A
bundance
120.0478
214.0890
83.0610
239.0876103.0215165.1053
138.0911 198.1848
282.1296 333.1292427.1715 450.1689355.0408 675.1624521.7238 598.6459 647.1061
S71
N,N'-(disulfanediylbis(ethane-2,1-diyl))diacetamide (1d) m/z = 236.97–237.17
RT: 0.00 - 10.01
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0
Time (min)
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Rela
tive A
bundance
RT: 2.65MA: 1087460145
2.943.07 3.20 8.91 9.082.44 3.490.19 5.660.69 7.27 9.535.470.82 7.87 8.183.971.17 9.781.76 5.04 7.144.452.17 4.77 6.42 7.52 8.776.685.81
NL:1.46E8
m/z= 236.97-237.17 MS JG219-11
JG199-18 #284 RT: 2.69 AV: 1 SB: 406 3.00-4.91 , 0.69-2.60 NL: 1.04E7T: FTMS + p ESI Full ms [70.0000-700.0000]
240 260 280 300 320 340 360 380 400 420 440 460 480 500
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lative
Ab
un
da
nce
237.0732
282.1311
259.1485
427.1734
351.1747313.1586 368.1049 453.6292335.1796268.2466253.1805 444.2001303.1382287.2226
405.0372 419.3152381.9603 481.4226465.1290
S72
N,S-diacetyl cysteamine (3b) m/z = 161.95–162.15
RT: 0.00 - 10.02
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0
Time (min)
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lative
Ab
un
da
nce
RT: 1.69MA: 221307459
1.83
1.88
1.93 8.737.47 8.578.458.097.412.02 6.782.13 6.526.41 9.718.776.200.23 9.602.430.61 0.91 1.29 2.72 3.823.48 5.923.96 4.60 4.85 5.17
NL:3.04E7
m/z= 161.95-162.15 MS JG220-4
JG220-4 #179 RT: 1.69 AV: 1 SB: 1003 0.00-1.50 , 2.02-10.02 NL: 5.44E7T: FTMS + p ESI Full ms [70.0000-700.0000]
70 80 90 100 110 120 130 140 150 160 170 180 190 200
m/z
0
10
20
30
40
50
60
70
80
90
100
110
120
130
140
150
160
170
180
190
200
210
220
230
240
250
260
270
Re
lative
Ab
un
da
nce
83.0602
162.0563
138.0898100.0751 183.1722
114.0904158.0252 198.1830
120.0466 140.998890.0546
77.0387
84.0636
181.156598.5115 164.0521145.1319 196.1674171.1472 184.5378131.0802 151.0947103.0495
81.5205
134.9853110.0592 127.0741
S73
4-[[2-(Acetylamino)ethyl]thio]-4-oxobutanoic acid (5b) m/z = 219.95–220.15
RT: 0.00 - 10.02
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0
Time (min)
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lative
Ab
un
da
nce
RT: 2.29MA: 1566632049
2.582.71 2.98 6.32 6.713.42 6.971.05 2.140.42 6.150.65 4.99 7.151.52 7.50 7.924.02 9.675.14 8.804.22 8.26 9.414.73 5.91 9.04
NL:2.26E8
m/z= 219.95-220.15 MS ECB445-C4
ECB445-C4 #242 RT: 2.29 AV: 1 SB: 541 2.49-5.35 , 0.00-2.25 NL: 2.32E8T: FTMS + p ESI Full ms [70.0000-700.0000]
80 100 120 140 160 180 200 220 240 260 280 300 320 340 360 380 400 420 440 460
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lative
Ab
un
da
nce
214.0863
220.0606
265.1177
83.0600120.0463
138.0893183.1716
158.0247 439.1139202.0503237.0869
258.0160
290.0229 309.1069
278.1127
342.5861 357.1422 382.6047 409.0466
S74
3-((2-acetamidoethyl)thio)-3-oxopropanoic acid (8b) m/z = 205.54–206.54
RT: 0.00 - 10.01
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0
Time (min)
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lative
Ab
un
da
nce
RT: 0.86MA: 768772457
1.18 1.32 9.580.570.42 1.84 6.232.02 9.47 9.816.452.94 3.442.42 3.94 4.43 4.78 5.00 7.106.11 6.70 9.187.727.475.22 8.608.20
NL:1.31E8
m/z= 205.54-206.54 MS CL030-Calib-20mM-1
CL030-Calib-20mM-1 #89 RT: 0.84 AV: 1 SB: 1037 0.99-10.01 , 0.00-0.80 NL: 1.01E8T: FTMS + p ESI Full ms [70.0000-700.0000]
70 80 90 100 110 120 130 140 150 160 170 180 190 200
m/z
0
10
20
30
40
50
60
70
80
90
100
110
120
130
140
150
160
170
180
190
200
210
220
230
240
250
260
270
280
Rela
tive A
bundance
206.0488
183.1749158.0275141.0008114.092090.0559 198.1858100.076577.0398 120.0484 181.1591164.0380 188.0382129.0664 145.1340 170.0276151.0971106.050786.0611
203.0851
O
O
SNH
HO
O
calculated excact mass
[M+H]+ = 206.0482
S75
4-((2-acetamidoethyl)thio)-2-hydroxy-4-oxobutanoic acid (9b) m/z = 236.04–236.06
RT: 0.00 - 10.02
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0
Time (min)
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lative
Ab
un
da
nce
RT: 0.90MA: 53114744
1.05
1.09
1.131.25 9.963.00 3.58 9.671.74 2.19 2.74 3.35
NL:7.55E6
m/z= 236.04-236.06 MS JG233-10
JG233-18 #96 RT: 0.91 AV: 1 SB: 504 1.24-5.25 , 0.00-0.80 NL: 8.56E7T: FTMS + p ESI Full ms [70.0000-700.0000]
100 150 200 250 300 350 400 450 500 550 600 650 700
m/z
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lative
Ab
un
da
nce
236.0583
281.1160
120.0479471.1094
190.0529
215.0935
258.0402 525.0292493.0913141.9584103.0216 289.9774 324.1580 425.1035449.1402
366.1321
166.1222
684.4061552.9889 607.6182 640.6078
S76
4.8. LC-MS chromatograms of thioester formation under prebiotic conditions
Table 1, Entry 3, Method A
Table 1, Entry 3, Method B
RT: 0.00 - 10.01
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0
Time (min)
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lative
Ab
un
da
nce
RT: 2.05MA: 91068406
2.17
2.280.26 0.280.59 2.330.69 2.50 9.44 9.601.09 9.351.12 3.381.42 8.796.212.74 5.07 8.773.56 5.09 6.19 6.383.73 4.43 4.64 6.575.95 6.92 8.857.27 8.227.967.58 8.55
NL:1.59E7
m/z= 219.56-220.56 MS JG214-1
RT: 0.00 - 10.02
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0
Time (min)
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lative
Ab
un
da
nce
RT: 1.98MA: 316703247
2.15
2.21
2.350.69 1.73 6.770.51 2.561.09 10.006.981.57 3.67 6.33 9.342.97 3.69 7.254.65 5.104.42 6.16 9.305.27 8.785.78 7.49 8.397.94
NL:4.82E7
m/z= 219.95-220.15 MS ECB494-2-A1
sample retention time 5b (min) peak area
1 2.05 9.82E+07
2 2.00 1.48E+08
3 2.04 1.31E+08
sample retention time 5b (min) peak area
1 1.98 3.17E+08
2 2.03 3.50E+08
3 2.03 3.04E+08
S77
Table 1, Entry 3, Method C
RT: 0.00 - 10.01
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0
Time (min)
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lative
Ab
un
da
nce
RT: 2.05MA: 172844401
2.22
2.24
2.350.51 9.711.85 2.46 6.671.09 1.310.36 8.813.110.52 9.606.346.20 6.724.063.773.43 5.074.21 8.775.214.69 5.96 6.98 9.297.69 7.87 8.12
NL:2.67E7
m/z= 219.95-220.15 MS ECB494-2-B1
sample retention time 5b (min) peak area
1 2.05 1.73E+08
2 2.03 1.84E+08
3 2.03 1.60E+08
S78
Table 1, Entry 4, Method A
RT: 0.00 - 10.01
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0
Time (min)
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lative
Ab
un
da
nce
RT: 0.86MA: 62919194
1.011.030.40
0.52 6.201.300.18 9.821.961.75 9.417.91 8.282.37 6.18 6.472.72 2.74 8.346.653.44 6.96 9.325.145.07 5.903.76 8.43 8.823.96 4.25 7.065.22 7.48 9.22
NL:1.24E7
m/z= 205.54-206.54 MS JG214-4
RT: 0.00 - 10.01
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0
Time (min)
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Re
lative
Ab
un
da
nce
RT: 1.54MA: 57053073
1.64
1.72
0.34 1.76 1.930.371.440.67 2.21 2.23 8.73 9.702.64
9.478.70 9.353.562.74 6.20 6.822.95 8.343.65 8.066.994.47 6.684.32 7.915.05 8.436.135.174.79 7.245.97 7.40 8.80
NL:8.06E6
m/z= 161.95-162.15 MS JG214-4
sample retention time 8b (min) peak area
1 0.86 8.24E+07
2 0.86 8.72E+07
3 0.85 7.65E+07
sample retention time 3b (min) peak area
1 1.54 5.71E+07
2 1.54 4.69E+07
3 1.54 4.64E+07
S79
Table 1, Entry 4, Method B
RT: 0.00 - 10.02
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0
Time (min)
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Rela
tive A
bundance
RT: 0.99MA: 281559510
0.40
1.210.54 6.18 6.37 8.287.806.45 7.156.131.40 8.617.721.46 5.91 9.53 9.662.672.310.20 8.63 9.072.81 4.403.18 3.64 5.544.824.17
NL:4.59E7
m/z= 205.54-206.54 MS JG218-5
RT: 0.00 - 10.02
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0
Time (min)
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Rela
tive A
bundance
RT: 1.70MA: 47783364
1.67
1.81
8.738.281.84
6.336.18 8.598.237.837.801.910.30 6.47 6.870.43 7.15 9.780.55 9.501.14 2.71 9.442.011.30 6.062.35 2.73 6.01
9.363.673.25 8.795.103.81 4.18 5.255.084.54 9.17
NL:6.79E6
m/z= 161.95-162.15 MS JG218-5
sample retention time 8b (min) peak area
1 0.97 3.09E+08
2 0.99 2.82E+08
3 0.97 2.71E+08
sample retention time 3b (min) peak area
1 1.70 4.77E+07
2 1.69 4.95E+07
3 1.65 4.00E+07
S80
Table 1, Entry 4, Method C
Table 1, Entry 5, Method A
RT: 0.00 - 10.01
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0
Time (min)
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Rela
tive A
bundance
RT: 1.01MA: 104590916
0.31
0.33
0.39
0.43
0.45
0.47
0.490.51
1.12
0.72 1.18
1.221.32 7.401.57 7.266.43 7.476.291.80 6.502.27 7.96 8.60 8.62 9.402.32 8.365.995.84 9.582.83 3.04 3.77 5.193.94 4.533.17 4.85
NL:1.63E7
m/z= 205.54-206.54 MS JG218-3
RT: 0.00 - 10.02
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0
Time (min)
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Rela
tive A
bundance
RT: 0.91MA: 13415877
0.94
0.56 1.04
1.060.55
7.657.09 8.478.08
NL:2.15E6
m/z= 236.04-236.06 MS JG242-1
sample retention time 8b (min) peak area
1 0.99 7.35E+07
2 0.96 1.10E+08
3 1.01 1.05E+08
sample retention time 9b (min) peak area
1 0.91 13415877
2 0.90 11846341
3 0.92 12366159
S81
Table 1, Entry 5, Method B
Table 1, Entry 5, Method C
RT: 0.00 - 10.01
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0
Time (min)
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Rela
tive A
bundance
RT: 0.88MA: 34090759
0.86
1.05
1.09
1.15
0.411.17
0.511.21
8.438.228.167.46 8.69
NL:2.85E6
m/z= 236.04-236.06 MS JG242-6
RT: 0.00 - 10.01
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0
Time (min)
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Rela
tive A
bundance
RT: 0.97MA: 7095792
0.99
1.02
0.941.07
1.14
1.18
1.22
0.59 1.26
0.56 1.27
0.53
0.51
8.698.617.65 8.42
NL:6.15E5
m/z= 236.04-236.06 MS JG242-7
sample retention time 9b (min) peak area
1 0.88 34376793
2 0.89 39158931
3 0.86 34090759
sample retention time 9b (min) peak area
1 0.97 7095792
2 0.98 7318094
3 0.96 7863899
S82
4.9. LC-MS chromatograms of the network combined with thioester formation
Table S-3, Entry 1
RT: 0.00 - 10.01
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0
Time (min)
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Rela
tive A
bundance
RT: 2.33MA: 48060218
2.29
2.27
2.480.67
0.710.62
0.75
2.54
2.600.82 2.72 5.240.48 2.822.19 5.22 8.875.323.14 9.671.601.51 3.74 8.924.913.87 4.38 8.826.485.56 5.76 7.29 7.836.506.41 8.24 8.45
NL:5.06E6
m/z= 219.95-220.15 MS ECB-508-1
RT: 0.00 - 10.01
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0
Time (min)
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Rela
tive A
bundance
RT: 0.94MA: 3413768
0.96
0.99
0.62
1.050.59
0.03
0.57 1.09
0.55 1.12
0.521.18
8.20 8.35
NL:5.24E5
m/z= 236.04-236.06 MS ECB-508-1
sample retention time 5b (min) peak area
1 2.33 4.81E+07
2 2.35 3.21E+07
3 2.33 3.54E+07
sample retention time 9b (min) peak area
1 0.94 3.41E+06
2 0.95 3.47E+06
3 0.94 3.34E+06
S83
Table S-3, Entry 2
RT: 0.00 - 10.02
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0
Time (min)
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Rela
tive A
bundance
RT: 0.96MA: 428650693
RT: 2.31MA: 24021058
0.90
0.88
0.78
0.74
0.70
0.62
0.58
0.54
2.40
2.441.31
1.45 2.500.42 2.24 3.463.44 3.48 8.882.99 4.16 4.38 9.558.860.16 5.00 9.879.294.55 5.12 5.40 6.545.83 7.726.83 8.437.16 7.88
NL:1.48E7
m/z= 219.95-220.15 MS ECB-509-A1
RT: 0.00 - 10.02
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0
Time (min)
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Rela
tive A
bundance
RT: 1.07MA: 206003250
0.99
0.44
0.61
1.321.41
1.53 1.95 2.160.03 2.59 2.84 6.13 8.00 8.18
NL:1.66E7
m/z= 236.04-236.06 MS ECB-509-A1
sample retention time 5b (min) peak area
1 2.31 2.40E+07
2 2.32 2.19E+07
3 2.31 2.13E+07
sample retention time 9b (min) peak area
1 1.07 2.06E+08
2 1.05 1.78E+08
3 1.07 2.03E+08
S84
Table S-3, Entry 3
RT: 0.00 - 10.02
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0
Time (min)
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Rela
tive A
bundance
RT: 0.97MA: 243856930
RT: 2.32MA: 18621876
0.93
0.82
0.75
0.72
0.70
0.64
1.13
0.59
0.57
1.17
0.54
2.291.21 2.34
2.26 2.380.52
1.240.412.43
1.390.39 3.541.43 2.21 2.49 3.663.49 4.96 5.13 8.912.85 9.700.09 9.438.874.714.254.00 5.28 5.75 8.936.84 7.28 7.816.49 8.648.356.04
NL:8.40E6
m/z= 219.95-220.15 MS ECB-509-B1
RT: 0.00 - 10.02
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0
Time (min)
0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Rela
tive A
bundance
RT: 1.04MA: 184818699
1.07
0.93
0.91
0.43
0.61
1.25
1.301.42
0.04 1.70 2.13 3.872.45 8.728.39
NL:1.74E7
m/z= 236.04-236.06 MS ECB-509-B1
sample retention time 5b (min) peak area
1 2.32 1.86E+07
2 2.31 2.58E+07
3 2.32 2.32E+07
sample retention time 9b (min) peak area
1 1.04 1.74E+08
2 1.06 2.09E+08
3 1.08 1.87E+08
S85
4.10. GC-MS chromatograms of authentic samples
N-acetylcysteamine (1b)
N-acetylcysteamine (1b) after derivatization
-1x10
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
2
2.2
2.4
+ TIC Scan 00601006.D
Counts (%) vs. Acquisition Time (min)2.6 2.8 3 3.2 3.4 3.6 3.8 4 4.2 4.4 4.6 4.8 5 5.2 5.4 5.6 5.8 6 6.2 6.4 6.6 6.8 7 7.2 7.4 7.6 7.8 8
5x10
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
+ Scan (3.717 min) 00601006.D
60.00
72.00119.10
463.40
Counts vs. Mass-to-Charge (m/z)60 80 100 120 140 160 180 200 220 240 260 280 300 320 340 360 380 400 420 440 460 480 500
2x10
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
+ TIC Scan 00301001.D
Counts (%) vs. Acquisition Time (min)2.6 2.8 3 3.2 3.4 3.6 3.8 4 4.2 4.4 4.6 4.8 5 5.2 5.4 5.6 5.8 6 6.2 6.4 6.6 6.8 7 7.2 7.4 7.6 7.8
6x10
0
1
2
3
4
5
6
7
8
9
+ Scan (5.803 min) 00301001.D
132.00
60.00
118.0086.00
104.00
192.00147.90 265.80 403.40
Counts vs. Mass-to-Charge (m/z)60 80 100 120 140 160 180 200 220 240 260 280 300 320 340 360 380 400 420 440 460 480
(N-acetylcysteamine
derivatized)
S86
4.11. GC-MS chromatograms of the network after thioester formation
Table S-3, Entry 1
1x10
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
+ TIC Scan 00801008.D
Counts (%) vs. Acquisition Time (min)2.4 2.6 2.8 3 3.2 3.4 3.6 3.8 4 4.2 4.4 4.6 4.8 5 5.2 5.4 5.6 5.8 6 6.2 6.4 6.6 6.8 7 7.2 7.4 7.6 7.8 8 8.2 8.4 8.6 8.8 9
5x10
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
+ Scan (3.392 min) 00801008.D
60.90
117.00
89.00
145.0073.00 99.90 128.8052.10 109.10 266.10177.60
Counts vs. Mass-to-Charge (m/z)50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200 210 220 230 240 250 260
6x10
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
+ Scan (3.794 min) 00801008.D
60.00
72.00119.0085.90 100.80 231.00143.10 213.20
Counts vs. Mass-to-Charge (m/z)50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200 210 220 230 240 250 260
4x10
0
0.5
1
1.5
2
2.5
3
+ Scan (4.487 min) 00801008.D
74.90
103.20
131.0058.90
145.70
Counts vs. Mass-to-Charge (m/z)60 80 100 120 140 160 180 200 220 240 260 280 300 320 340 360 380 400 420 440 460 480 500
(pyruvate)
Glyoxylate + pyruvate + Fe2+
(70 °C, 1 h) then addition of thiol + KHSO4 (UV-A, 3 h)
pyruvate
thiol
glyoxylate
Thiol
derivatized
HKG isocitrate
(glyoxylate)
α-ketoglutarate
(thiol)
OPD
Pyruvate adducts
S87
4x10
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
+ Scan (4.730 min) 00801008.D
101.00
95.1054.80128.70112.80
67.50
158.50 284.80
Counts vs. Mass-to-Charge (m/z)50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200 210 220 230 240 250 260 270 280 290 300 310 320 330 340 350 360 370 380 390 400 410
5x10
0
1
2
3
4
5
6
7
8
9
+ Scan (5.546 min) 00801008.D
60.00
132.00
86.00
117.90
103.90
191.00145.00 313.00 453.70335.60
Counts vs. Mass-to-Charge (m/z)60 80 100 120 140 160 180 200 220 240 260 280 300 320 340 360 380 400 420 440 460 480 500
5x10
0
0.25
0.5
0.75
1
1.25
1.5
1.75
2
+ Scan (6.164 min) 00801008.D
100.00
127.0070.90
81.80116.10 214.80172.20145.70
Counts vs. Mass-to-Charge (m/z)60 80 100 120 140 160 180 200 220 240 260 280 300 320 340 360 380 400 420 440 460 480 500
4x10
0
1
2
3
4
5
+ Scan (6.365 min) 00801008.D
71.00
117.10
98.80
55.0088.90 145.00
126.70
216.90173.10154.80 265.20
475.40200.80 245.20
Counts vs. Mass-to-Charge (m/z)50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200 210 220 230 240 250 260 270 280 290 300 310 320 330 340 350 360 370 380 390 400 410 420 430 440 450 460 470 480
4x10
0
0.2
0.4
0.6
0.8
1
1.2
1.4
+ Scan (6.820 min) 00801008.D
129.10
157.20
85.00 184.90100.6061.00
71.00138.70
Counts vs. Mass-to-Charge (m/z)60 80 100 120 140 160 180 200 220 240 260 280 300 320 340 360 380 400 420 440 460 480 500
(thiol derivatized +
malate)
(OPD)
(isocitrate) [M – H – 90]+
[M – H – 118]+
(HKG)
S88
Table S-3, Entry 2
1x10
0
1
2
3
4
5
6
7
8
9
+ TIC Scan 01301014.D
Counts (%) vs. Acquisition Time (min)2.4 2.6 2.8 3 3.2 3.4 3.6 3.8 4 4.2 4.4 4.6 4.8 5 5.2 5.4 5.6 5.8 6 6.2 6.4 6.6 6.8 7 7.2 7.4 7.6 7.8 8 8.2 8.4 8.6 8.8 9
4x10
0
0.5
1
1.5
2
2.5
+ Scan (3.187 min) 01301014.D
70.90
98.80
55.20
85.10 128.90
143.80
Counts vs. Mass-to-Charge (m/z)50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200 210 220 230 240 250 260 270 280 290 300 310 320 330 340 350 360 370 380 390 400 410 420 430 440 450 460 470 480
4x10
0
0.5
1
1.5
2
2.5
3
+ Scan (3.218 min) 01301014.D
114.90
84.90 133.1056.80
72.1098.70
Counts vs. Mass-to-Charge (m/z)50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200 210 220 230 240 250 260 270 280 290 300 310 320 330 340 350 360 370 380 390 400 410 420 430 440 450 460 470 480
4x10
0
0.5
1
1.5
2
2.5
3
3.5
+ Scan (3.395 min) 01301014.D
117.1061.00
88.90
51.80 145.3075.10
101.20131.00
Counts vs. Mass-to-Charge (m/z)60 80 100 120 140 160 180 200 220 240 260 280 300 320 340 360 380 400 420 440 460 480 500
6x10
0
0.25
0.5
0.75
1
1.25
1.5
1.75
2
2.25
2.5
+ Scan (3.834 min) 01301014.D
60.00
71.90119.00
86.10 140.10 426.70346.40282.80209.30
Counts vs. Mass-to-Charge (m/z)60 80 100 120 140 160 180 200 220 240 260 280 300 320 340 360 380 400 420 440 460 480 500
pyruvate
thiol
glyoxylate
Glyoxylate + pyruvate + thiol + Fe2+
(70 °C, 1 h) then addition of K2S2O8 (70 °C, 3 h)
(pyruvate)
Thiol
derivatized
+ malate
(thiol)
malonate
levulinate
mesaconate
α-ketoglutarate
Pyruvate
adducts
(levulinate)
S89
5x10
0
1
2
3
4
5
6
+ Scan (4.073 min) 01301014.D
112.90
141.00
85.0069.00
98.90 170.90127.90 388.80
Counts vs. Mass-to-Charge (m/z)50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200 210 220 230 240 250 260 270 280 290 300 310 320 330 340 350 360 370 380 390 400 410 420 430 440 450 460 470 480
5x10
0
0.5
1
1.5
2
2.5
+ Scan (4.489 min) 01301014.D
75.00
102.90
131.00
59.1087.90
113.30 145.80304.30
Counts vs. Mass-to-Charge (m/z)60 80 100 120 140 160 180 200 220 240 260 280 300 320 340 360 380 400 420 440 460 480 500
5x10
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
+ Scan (4.728 min) 01301014.D
100.90
143.0067.90 85.90
113.00
128.8058.10156.90
Counts vs. Mass-to-Charge (m/z)50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200 210 220 230 240 250 260 270 280 290 300 310 320 330 340 350 360 370 380 390 400 410 420 430 440 450 460 470 480
5x10
0
1
2
3
4
5
6
7
+ Scan (5.543 min) 01301014.D
59.90
132.00
86.00
118.00
104.00
190.90144.80 170.10 341.40283.40216.50
Counts vs. Mass-to-Charge (m/z)60 80 100 120 140 160 180 200 220 240 260 280 300 320 340 360 380 400 420 440 460 480 500
(glyoxylate)
(“mesaconates”)
(thiol derivatized +
malate)
S90
Table S-3, Entry 3
1x10
1
2
3
4
5
6
7
8
+ TIC Scan 01501016.D
Counts (%) vs. Acquisition Time (min)2.4 2.6 2.8 3 3.2 3.4 3.6 3.8 4 4.2 4.4 4.6 4.8 5 5.2 5.4 5.6 5.8 6 6.2 6.4 6.6 6.8 7 7.2 7.4 7.6 7.8 8 8.2 8.4 8.6 8.8 9
5x10
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
+ Scan (3.186 min) 01501016.D
99.00
55.0070.90
128.90
144.0085.40 116.00202.40 230.30
Counts vs. Mass-to-Charge (m/z)50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200 210 220 230 240 250 260 270 280 290 300 310 320 330 340 350 360 370 380 390 400 410 420 430 440 450 460 470 480
5x10
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
+ Scan (3.220 min) 01501016.D
85.0058.00
115.10133.10
73.70 98.80
Counts vs. Mass-to-Charge (m/z)50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200 210 220 230 240 250 260 270 280 290 300 310 320 330 340 350 360 370 380 390 400 410 420 430 440 450 460 470 480
4x10
0
1
2
3
4
5
6
+ Scan (3.395 min) 01501016.D
116.9061.00
89.00
71.90 145.10436.6098.80
Counts vs. Mass-to-Charge (m/z)60 80 100 120 140 160 180 200 220 240 260 280 300 320 340 360 380 400 420 440 460 480 500
6x10
0
0.5
1
1.5
2
2.5
3
+ Scan (3.850 min) 01501016.D
60.00
72.00118.90
138.70 499.20196.40 304.10235.40
Counts vs. Mass-to-Charge (m/z)60 80 100 120 140 160 180 200 220 240 260 280 300 320 340 360 380 400 420 440 460 480 500
pyruvate
thiol
(pyruvate)
Glyoxylate + pyruvate + thiol + Fe2+
(70 °C, 3 h) then addition of K2S2O8 (70 °C, 3 h)
Thiol
derivatized
+ malate
(thiol)
(levulinate)
levulinate
malonate
mesaconate
α-ketoglutarate
Pyruvate
adducts
S91
5x10
0
1
2
3
4
5
+ Scan (4.074 min) 01501016.D
112.90
140.9084.90
69.0098.80 171.00126.40
Counts vs. Mass-to-Charge (m/z)50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200 210 220 230 240 250 260 270 280 290 300 310 320 330 340 350 360 370 380 390 400 410 420 430 440 450 460 470 480
5x10
0
0.25
0.5
0.75
1
1.25
1.5
1.75
2
2.25
+ Scan (4.731 min) 01501016.D
100.90
142.9068.00
85.90
58.90
157.10113.00 249.70
Counts vs. Mass-to-Charge (m/z)50 60 70 80 90 100 110 120 130 140 150 160 170 180 190 200 210 220 230 240 250 260 270 280 290 300 310 320 330 340 350 360 370 380 390 400 410 420 430 440 450 460 470 480
5x10
0
1
2
3
4
5
6
7
8
+ Scan (5.552 min) 01501016.D
60.00
131.9086.00
72.00118.00
103.90
191.20147.90 168.70 233.10
Counts vs. Mass-to-Charge (m/z)60 80 100 120 140 160 180 200 220 240 260 280 300 320 340 360 380 400 420 440 460 480 500
(“mesaconates”)
129.00
(thiol derivatized +
malate)
S92
5. Supporting references
1. Muchowska, K. B. et al. Metals promote sequences of the reverse Krebs cycle. Nat. Ecol. Evol.
1, 1716–1721 (2017).
2. Varma, S. J., Muchowska, K. B., Chatelain, P. & Moran, J. Native iron reduces CO2 to
intermediates and end-products of the acetyl CoA pathway. Nat. Ecol. Evol. 2, 1019–1024
(2018).
3. Muchowska, K. B., Varma, S. J. & Moran, J. Synthesis and breakdown of universal metabolic
precursors promoted by iron. Nature 569, 104–107 (2019).
4. Shewring, J. R. et al. Multimodal Probes: Superresolution and Transmission Electron
Microscopy Imaging of Mitochondria, and Oxygen Mapping of Cells, Using Small-Molecule
Ir(III) Luminescent Complexes. Inorg. Chem. 56, 15259–15270 (2017).
5. Fujimoto, N., Nakahodo, T. & Fujihara, H. Synthesis of Anionic Sulfonate-functionalized
Conducting Polymer Nanotubes and Selective Confinement of Cationic Gold Nanoparticles in
Their Inner Cavities via Electrostatic Interaction. Chem. Lett. 42, 1394–1396 (2013).
6. Field, L., Owen, T. C., Crenshaw, R. R. & Bryan, A. W. Organic Disulfides and Related
Substances. IV. Thiolsulfonates and Disulfides Containing 2-Aminoethyl Moieties. J. Am.
Chem. Soc. 83, 4414–4417 (1961).
7. Guntaka, N. S., Healy, A. R., Crawford, J. M., Herzon, S. B. & Bruner, S. D. Structure and
Functional Analysis of ClbQ, an Unusual Intermediate-Releasing Thioesterase from the
Colibactin Biosynthetic Pathway. ACS Chem. Biol. 12, 2598–2608 (2017).
8. Keddie, D. J., Grande, J. B., Gonzaga, F., Brook, M. A. & Dargaville, T. R. Amphiphilic
silicone architectures via anaerobic Thiol-Ene chemistry. Org. Lett. 13, 6006–6009 (2011).
9. Hagen, A., Poust, S., Katz, L. & Keasling, J. D. Producing adipic acid and related compounds
using hybrid polyketide synthases. 1–53 (2017).
10. Lowell, A. N. et al. Chemoenzymatic Total Synthesis and Structural Diversification of
Tylactone-Based Macrolide Antibiotics through Late-Stage Polyketide Assembly, Tailoring,
and C-H Functionalization. J. Am. Chem. Soc. 139, 7913–7920 (2017).
11. Palyam, N. & Majewski, M. Organocatalytic syn-Aldol Reactions of Dioxanones with (S)-
Isoserinal Hydrate: Synthesis of L-Deoxymannojirimycin and L-Deoxyidonojirimycin. J. Org.
Chem. 74, 4390–4392 (2009).
S93
12. Blaquiere, N., Shore, D. G., Rousseaux, S. & Fagnou, K. Decarboxylative ketone aldol
reactions: Development and mechanistic evaluation under metal-free conditions. J. Org. Chem.
74, 6190–6198 (2009).
download fileview on ChemRxivSupporting Information V-14.pdf (6.31 MiB)